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 SUBCLINICAL CARDIOVASCULAR DISEASE, VASCULAR HEALTH AND 
MARKERS OF RISK 
Laura Lynn Liebenauer Schott, PhD 
University of Pittsburgh, 2007
 
Cardiovascular diseases are a leading cause of morbidity and mortality.  To facilitate 
early treatment and prevention, the relationship between risk markers and measures of 
subclinical disease should be determined.  This dissertation examines how putative markers of 
risk, including traditional cardiovascular risk factors, rheumatoid arthritis and negative affect, are 
associated with measures of subclinical cardiovascular disease and vascular health.   
First, the relationship of traditional risk factors with carotid artery intima-media thickness 
(IMT) is evaluated in 453 healthy middle-aged women.  It is unknown whether segment-specific 
associations exist when accounting for the interdependence across IMT locations.  Results show 
unique positive associations between common carotid IMT and weight, bifurcation IMT and 
smoking and systolic blood pressure, and internal carotid IMT and apoprotein B. 
Second, it is postulated that the evaluation of carotid diameters augments knowledge of 
associations between rheumatoid arthritis and IMT and plaque.  In 93 middle-aged patients, 
diagnosis of rheumatoid arthritis is associated with larger lumen and interadventitial diameters 
compared to 93 matched healthy women; whereas plaque prevalence is not statistically different 
and carotid IMT is similar, showing potential influences of vascular adaptation.  Positive 
associations are demonstrated between carotid measures and rheumatoid arthritis medications, 
hypothyroidism and inflammatory markers.   
Third, associations between negative psychosocial indices and brachial artery flow-
mediated dilation (FMD) are examined in 332 healthy older men and women.  It is not known 
whether a link exists when considering multiple measures of negative affect in a large sample of 
both sexes.  After controlling for traditional cardiovascular risk factors, FMD is inversely 
associated with hostility and general anger scores for men, and anger suppression in women.   
As demonstrated in this dissertation, associations between cardiovascular health and risk 
markers are evident early in the disease process.  When evaluating cardiovascular disease risk, 
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including co-morbid conditions and psychosocial symptoms along with traditional risk factors is 
of public health relevance.  Additionally, the implications of appropriate statistical methods, the 
effects of vascular adaptation, and the importance of including women in epidemiologic research 
are illustrated. 
In conclusion, evaluating associations between markers of risk and subclinical 
cardiovascular disease and vascular health provides insight into the broader epidemic of 
cardiovascular disease.  
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PREFACE 
The motto for this degree could have been, “nothing’s going to stop me.”  Completion of 
my PhD has been a long and slow moving process, but I’ve managed to keep it going amidst 
working full-time, planning a wedding, building & moving into a new house and having two 
children.  There have been lots of starts and stops, with very productive time periods, and weeks 
where I didn’t even think about it; and of course lots of drafts, revisions and resubmissions to 
various journals.  It’s almost hard to remember the coursework I started nine years ago and 
preliminary exam a few years later; or even getting the first paper published and completing the 
overview/comprehensive exam.  Nonetheless, here I am today with a finished product.   
I’ve had help and encouragement along the way, some since the beginning, and from 
others for segments along the way.  Thank you to my co-workers here at the University of 
Pittsburgh and previously at the National Institutes of Health and those involved with the ‘Acute 
Care for Elders’ program in Ohio, who contributed to my affinity to research, broadened my 
knowledge and skills, and were instrumental in influencing my decision to pursue and ability to 
complete a doctoral degree.   
I’d like to acknowledge my dissertation committee whose knowledge and thoughtful 
critiques have been very helpful.  I’ve learned from both your participation in my dissertation 
and through my employment experiences with you.  And, a special thank you to the co-authors 
on each of the individual papers, who have contributed to their success and certainly made each 
better.   
Finally, I’d like to extend a very warm thank you to my family and friends many of 
whom have been especially supportive and encouraging both in this most recent pursuit and in 
daily life; with a special acknowledgement to Barb, Deb & Gina and to my immediate family – 
Mom & Dad, my sister Donna, my brother Mark & his family, my husband Kris, and the two 
most fantastic kids in the world, Benjamin & Lydia. 
1.0  INTRODUCTION AND OVERVIEW 
1.1 OVERVIEW 
Given that cardiovascular disease continues to be a leading cause of morbidity and mortality,41,42 
it is important to identify individuals with subclinical disease, so that treatment and prevention 
can be applied early in the disease process.  Ultrasound evaluation of peripheral arteries, namely 
carotid and brachial, provides an easy, noninvasive method for assessing vascular health and 
aging and thus provides information on subclinical cardiovascular disease.  Although subclinical 
ultrasound measures are not yet part of standard clinical care, they are useful research tools given 
their strong association with both risk factors and health outcomes.  Research measures 
commonly used to detect early atherosclerosis and evaluate vascular health include carotid 
intima media thickness (IMT), lumen diameter, interadventitial diameter and plaque prevalence, 
and brachial artery flow-mediated dilation (FMD).  Of particular interest is how putative markers 
of risk, including traditional cardiovascular risk factors, specific diseases/conditions and 
psychosocial traits, are associated with these subclinical disease measures.   
The ensuing body of work examines three separate but related aspects of subclinical 
cardiovascular disease and vascular health and aging.  First, classic cardiovascular risk factors 
are examined in conjunction with segment-specific IMT.  This is important because unique 
associations by segment are driven by the underlying biology, and an understanding of how 
atherosclerosis develops may promote more targeted treatment.  The novelty of this paper is the 
use of a mixed statistical model approach to control for the correlation in IMT between 
segments, thus allowing potential differences in vessel areas to be compared directly.  Second, 
atherosclerosis in women with rheumatoid arthritis is assessed in comparison to healthy women 
and in conjunction with measures of rheumatoid arthritis severity.  This line of research is 
imperative given the much higher incidence of cardiovascular disease morbidity and mortality in 
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patients with rheumatoid arthritis relative to the general population.  We make a unique 
contribution to the existing literature by considering carotid artery diameter along with IMT and 
plaque, which are the measures of early atherosclerosis typically evaluated.  Third, we use FMD 
to assess the relationship between negative affect and endothelial dysfunction in a sample of 
healthy older adults.  Substantiating evidence of a link between psychosocial constructs and 
subclinical cardiovascular disease promotes the notion that influences beyond traditional 
cardiovascular risk factors should be considered when evaluating heart health.  By including 
multiple measures of negative affect in both men and women, this paper broadens the previously 
published research on FMD and psychosocial measures. 
1.2 CARDIOVASCULAR DISEASE 
Heart health is an important public health concern and research on subclinical cardiovascular 
disease and vascular health and aging enables varying aspects of cardiovascular disease to be 
considered and addressed.  Following is a brief synopsis of the global and national impact of 
heart disease and a review of subclinical cardiovascular disease and vascular health.  Awareness 
of the magnitude and spectrum of causes of cardiovascular disease are the impetus for the 
individual papers, which examine the associations of traditional cardiovascular risk factors, 
rheumatoid arthritis and measure of negative affect with atherosclerosis and vascular health. 
1.2.1 Facts about Cardiovascular Disease 
Reviewing some of the statistics on cardiovascular disease makes the enormity of the problem 
readily apparent.  Cardiovascular disease is a group of disorders involving diseases of the blood 
vessels supplying the heart, brain, arms and legs, damage or malfunction of the heart muscle, 
valves and structure, and dislodging of blood clots in the veins.42  According to the World Health 
Organization, nearly one-third of all deaths world-wide are due to cardiovascular disease, which 
is more than any other cause.42  By 2015, it is estimated that the number of deaths due to 
cardiovascular disease will rise to 20 million people, a 2.5 million increase from statistics for 
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2005.42  For the approximately 20 million people who survive heart attacks and stroke, 
continuing medical care is needed,42 which has substantial financial and quality of life 
implications.   
In the United States of America, the prevalence of cardiovascular disease was 37% in 
2004; it is the leading cause of death for both sexes and all racial/ethnic groups; and it has been 
the number one killer for every year but one since 1900.43-45  In 2006, the estimated cost (direct 
and indirect) of cardiovascular diseases and stroke was $403.1 billion.44  For more than past two 
decades, the number of cardiovascular disease deaths for women has exceeded men, with males 
representing about 47%.43  For men, about one-third of cardiovascular disease deaths occur prior 
to the average life expectancy age of 75 years old.43,44  One-third of all adult females has some 
form of cardiovascular disease, and the number of cardiovascular disease deaths for women 
exceeds the next seven causes combined.43,46  Of those who die suddenly of coronary heart 
disease, 50% of men and 64% of women have no previous symptoms.43,47  Thus, continued 
research into early identification, including vascular health and markers of risk, is needed. 
1.2.2 Subclinical Cardiovascular Disease and Vascular Health 
Atherosclerosis and arteriosclerosis together form the foundation for cardiovascular diseases 
including coronary heart disease, and stroke, congestive heart failure and renal failure, 
respectively.  Atherosclerosis includes subclinical features of stenosis, calcification, plaque and 
rupture, while arteriosclerosis encompasses changes in collagen, degeneration of elastin, wall 
thickening and arterial dilation.  Clinical and research evaluation of these features include 
structural (e.g. plaque, wall thickening and calcification) and functional (e.g. arterial dilatation, 
vascular stiffness, reactive hyperemia) measures.48,49  Further, while most risk factors (e.g. 
inflammation, inactivity, smoking, obesity) influence both atherosclerosis and arteriosclerosis, 
some may be more influential for one or the other (e.g. lipids and atherosclerosis; blood 
pressure/age/insulin resistance and arteriosclerosis).  Here we will consider both atherosclerosis 
and arteriosclerosis as indicators of subclinical cardiovascular disease and vascular health and 
aging. 
Atherosclerosis, the accumulation of plaques, or fatty deposits on the arterial walls, is the 
cause of most acute cardiovascular events and accounts for almost 75% of all cardiovascular 
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disease deaths.42,44,45,50  As reviewed by Faxon and colleagues from the Atherosclerotic Vascular 
Disease 2004 Conference,51 a typical sequence involves50,52 accumulation in the subendothelium 
of low density lipoproteins that are oxidized by smooth muscle cells and macrophages.  
Concurrent with the accumulation of minimally oxidized low density lipoproteins is the 
development of inflammation, including instigation of adhesion molecules.  Also influential is 
the bioavailability of nitric oxide and other mediators, which provide a balance between 
vasoconstriction and vasodilatation, anticoagulation and thrombosis, and modulation of the 
inflammation.  These substances and processes result in release of cytokines and growth factors 
that attract additional monocytes, followed by smooth muscle cell proliferation and foam cell 
accumulation, which result in plaque growth.  Vascular adaptation enables the artery vessel to 
constrict or enlarge in size during the development of atherosclerosis in an effort to maintain a 
constant level of blood flow.  However, when the plaque encompasses approximately 40% of the 
vessel area or greater, arterial diameter no longer enlarges and the lumen narrows.  The 
restriction or blockage of blood flow and erosion or rupture in plaque leads to cardiovascular 
outcomes including heart attack and stroke.   
Underlying the initiation and progression of subclinical cardiovascular disease are genetic 
and lifestyle factors that influence vascular health.  A first-degree relative with early-onset 
atherosclerotic cardiovascular disease (less then age 55 years in men and less than age 65 year in 
women) or having a condition where increased IMT is seen at a very early stage of atherogenesis 
(e.g. diabetes mellitus, systemic lupus erythematosus) increases one’s risk for heart disease.  An 
unhealthy diet, physical inactivity and smoking all contribute to the formation of traditional 
cardiovascular risk factors including, obesity, hypertension, poor lipid profile and diabetes.42,53,54  
Additionally, these risk indicators are interacting with and influenced by psychosocial and 
environmental aspects such as, negative disposition, stress, and socioeconomic status.55-57  All of 
the above factors, along with aging itself58,59 and the fundamental role of inflammation,52 start in 
motion the pathophysiological processes that result in the initial insult to the endothelium, 
accumulation of the fatty streak, atheroma formation and thrombosis promotion.  This damage 
often occurs prior to any overt cardiovascular event and thus often progresses undetected. 
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1.2.3 Topics of Subclinical Disease and Vascular Health Presented 
Endothelial function, atherosclerosis and arterial diameter are useful indicators of subclinical 
cardiovascular disease and vascular health, and thus evaluation of these conditions provides 
insight into cardiovascular disease.  Not surprisingly, these measures have been linked to disease 
outcomes, including coronary artery disease, myocardial infarction and stroke.1,2,60-67  
Furthermore, evaluating measures of early atherosclerosis and vascular health, along with related 
markers of risk may help identify those in jeopardy, lead to new areas of research and treatment, 
and potentially alleviate some of the burden of cardiovascular disease.   
Of particular interest is the assessment of vascular health and aging in women, who are 
underrepresented in cardiovascular disease research.68-70  Two of the following papers use 
female-only samples (Chapters 2 & 3), while the third evaluates both men and women (Chapter 
4).  Special attention will also be paid to the statistical methodology employed, the effects of 
aging, and the implications of hemodynamics of the vasculature.  The following sections will 
review individual ultrasound measures and putative markers of risk along with the existing 
literature on these topics.  In evaluating measures of subclinical cardiovascular disease and 
vascular health in association with putative markers of risk, we plan to address some of the 
issues underlying the public health significance of heart disease. 
1.3 ULTRASOUND MEASURES 
Ultrasound measures of subclinical cardiovascular disease are used to evaluate endothelial 
function, early atherosclerosis and vascular health.  Scanning is generally done in a dimly lit 
testing room with a participant in the supine position after several minutes of rest.  Carotid and 
brachial arteries are examined using an ultrasound scanner equipped with a linear array imaging 
probe.  These measures are sound indicators of subclinical cardiovascular disease and useful 
tools when examining associations with putative risk markers.71,72  Carotid ultrasound measures 
of IMT, plaque, lumen diameter, and interadventitial diameter are useful for evaluating early 
systemic atherosclerosis and are informative measures of vascular health.73-77  Ultrasound 
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imaging of endothelial-dependent FMD evaluates vasodilatation and dysfunction of the brachial 
artery.78,79 
1.3.1 Intima-Media Thickness 
Carotid arteries can be viewed via ultrasound in transverse and longitudinal projections.  For the 
common carotid artery segment, both near and far walls are normally examined just proximal to 
the bifurcation.  For the bifurcation area, internal carotid, and external carotid artery 
measurements are generally taken of the far walls only (since near walls cannot be consistently 
visualized).  Digitized images are used to trace the medial-adventitial and intima-lumen 
interfaces across 1-cm lengths and compute IMT for each segment.  IMT can be summarized as 
the average or as the maximum value of all or some segments.77  Additionally, the common 
carotid artery is used as a single indicator of IMT in early atherosclerosis.8,80  The ultrasound 
laboratory at the University of Pittsburgh calculates average IMT from the mean of both the right 
and left carotid arteries of three segments (internal, bifurcation and common; 8 locations total).30 
Carotid IMT is considered a marker of early atherosclerosis, predicts future risk of 
cardiovascular disease, and has been found to be high in individuals with coronary heart disease 
and myocardial infarction (IMT ≥ 0.73 mm and ≥ 1 mm, respectively).1,2  Cardiovascular risk 
factors, such as high blood pressure, body mass index and cholesterol, are associated with 
average and maximum carotid IMT.3-7,81-83  To detect the burden of preclinical cardiovascular 
disease in patients with rheumatoid arthritis, use of noninvasive measures such as carotid IMT 
has been promoted.84-99  In the following chapters we will look at average IMT in conjunction 
with segment-specific IMT in healthy women (Chapter 2), as well as the common carotid artery 
in rheumatoid arthritis analyses (Chapter 3). 
1.3.2 Segment-Specific Intima-Media Thickness  
Three segments are typically considered when examining IMT by location; these include the 
common carotid artery, internal carotid artery and the arterial bifurcation; with some 
investigators combining the internal and bifurcation areas of the vessel.  Body mass index, high 
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blood pressure, cholesterol and other traditional cardiovascular risk factors have been explored in 
conjunction with segment-specific locations of IMT.8-13   
While looking at multiple segment averages provides reliability and precision, 
examination of individual segments provides worthwhile information.  Differences in blood 
flow, cellar processes and influences of the risk factors themselves suggest it may be beneficial 
to look at IMT at specific locations along the carotid artery.  It has been reported that the 
association between coronary and carotid atherosclerosis is only marginally increased when IMT 
in the internal and bifurcation segments is added to the common.8  We believe unique 
information can be gained by looking at the three individual carotid IMT segments (Chapter 2). 
1.3.3 Carotid Plaque 
Carotid arteries can also be evaluated for the presence of eccentric focal plaque in the 
bifurcation, internal and common areas.  Plaque is typically defined as a distinct area protruding 
into the vessel lumen with ≥ 50% thickness than the surrounding area.  For group comparisons, 
degree of plaque may be dichotomize as presence of plaque versus no plaque, categorized as 
no/small plaque (< 30% of vessel diameter) versus medium/large/multiple plaques (≥ 30% 
stenosis), or summed as the total number of plaques.  Notably, while degree of stenosis (i.e. 
plaque size and number of lesions) is important in clinical outcomes, plaque vulnerability and 
composition (i.e. plaque type) are more likely to influence rupture and erosion.100-105 
The risk of plaque disruption is a function of rupture triggers (i.e. extrinsic effects) and 
vulnerability of the plaque (i.e. intrinsic effects).100-105  Major determinants of vulnerability are 
thickness of the fibrous cap, size and consistency of the atheromatous core, calcification burden 
and pattern, endothelial denudation, and plaque inflammation within the cap.  Biomechanical and 
hemodynamic forces acting extrinsically on the plaque include location of the plaque, shear 
stress, myocardial susceptibility, and blood coagulability.  And stability of the plaque includes 
evaluation of both structural and functional properties.102  Clinical outcomes can be linked to 
plaque rupture, which is most common, as well as plaque erosion and lumen occlusion.100-105 
Like IMT, carotid plaque is a measure of subclinical atherosclerosis.  Carotid plaque has 
been linked with increased age, smoking, higher blood pressure, hypercholesterolemia and 
ischemic stroke.39,60,106,107  Plaque is most commonly found in the carotid bifurcation.39 
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1.3.4 Carotid Artery Diameter  
Lumen diameter is measured as the distance between the lumen-intima interfaces of the common 
carotid artery, where the walls are parallel and there is no evidence of plaque.  Interadventitial 
diameter is measured as the distance between the adventitia-media interfaces.  Typically, these 
widths are calculated by averaging the distances of several measurements taken across a pre-
specified segment. 
Larger lumen and interadventitial diameters are markers of vascular aging.  Arterial 
dilatation (i.e. vascular remodeling) is considered to begin as an adaptive response to changes in 
wall shear stress concomitant with increased wall thickness.63,74,75,108-110  Previous cross-sectional 
analyses show increased carotid diameters are positively associated with hypertension, diabetes, 
coronary heart disease, myocardial infarction and left ventricular mass.61-63  Increased diameter 
has also been found to be independently associated with traditional cardiovascular risk factors 
including male sex, increased weight, high blood pressure and pack-years of smoking.9,62,75,111,112   
In the general population, carotid arteries free of atherosclerosis and unexposed to risk factors 
maintain normal size with aging.75  Here we will take a novel approach to comparing early 
atherosclerosis in patients with rheumatoid arthritis and healthy women by examining lumen and 
interadventitial diameters in addition to IMT and plaque (Chapter 3). 
1.3.5 Brachial Artery Flow-Mediated Dilation and Endothelial Dysfunction 
For the measurement of brachial artery FMD,78,79 a blood pressure cuff is typically placed distal 
to the elbow with the arm extended out on a board and pillow perpendicular to the body.  
Baseline brachial lumen diameter is computed as the distance between the lumen-intima 
interfaces 1-2 centimeters proximal to the antecubital fossa.  An ischemic trigger at the forearm 
is achieved by inflating a blood pressure cuff approximately 30 mmHg above the participant’s 
systolic pressure or greater than 250 mmHg for 4-5 minutes.  After release of the cuff, brachial 
artery images are obtained over several minutes and usually digitized for later scoring.  At pre-
specified time intervals, end-diastolic images from separate cardiac cycles are averaged from 
measurements taken across small arterial segments.  Absolute change in diameter is calculated as 
the peak (widest) of these diameter measures minus the baseline brachial diameter.  FMD is 
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calculated using the absolute difference (i.e. change in diameter) divided by the baseline brachial 
diameter times one-hundred.79   
The vascular endothelium is critical in vascular growth, vasoprotection and 
vasoregulation.  Impaired vasodilatation is associated with cardiovascular risk factors, such as 
increased age, systolic blood pressure, and body mass index and with lipid-lowering medication 
and smoking;78,113-117 Endothelial dysfunction is one of the earliest signs of insult in the 
cardiovascular disease continuum and is significantly related to atherogenesis.118,119  It is 
associated with cardiovascular outcomes and has been suggested as a biomarker of disease, 
similar to IMT and coronary calcification (reviewed by 64,120,121).   
For evaluation of endothelial dysfunction, brachial artery FMD is an easy to assess, non-
invasive technique.78,122,123  A higher FMD value indicates greater vasodilatation capacity, and 
thus healthier endothelial function.  FMD, a measure of impaired vasodilatation, is thought to 
reflect nitric oxide bioavailability and the effects of shear stress on the endothelium.124-127  For 
healthy populations, mean values for FMD range from -3 to 26%,113,128,129 and although there is 
great overlap amongst groups, values for coronary artery disease and diabetic patients are 
generally lower.78,130  FMD is considered an endothelium-dependent process that manifests the 
relaxation of a conduit artery when exposed to increase flow and as such, is also referred to as 
reactive-hyperemia.131  It is related to traditional cardiovascular risk factors,117 provides a 
surrogate marker for health of the coronary arteries,130,132,133 and is an independent predictor of 
cardiac risk and events.65,134,135,135  FMD and has been shown to improve with treatment.136,137  In 
Chapter 4, FMD will be used to evaluate the influences of negative affect on endothelial 
dysfunction. 
1.3.6 Inter-relationship, Reproducibility and Application  
While each of the above ultrasound measures conveys unique information, they are clearly 
interrelated.  FMD is inversely related to IMT,118,119 and evidence of endothelial dysfunction has 
been found prior to the development of measurable atherosclerosis.119,138  It has been suggested 
that damage to the endothelium is required before risk factors can “induce” atherosclerotic 
changes in the arterial wall.  Healthy young adults with FMD evidence of endothelial 
dysfunction and cardiovascular risk factors are at increase risk for thickened carotid arterial 
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walls.119  Presence of plaque or stenosis is strongly and positively associated with IMT and 
occurs subsequent to foam cell accumulation and wall thickening.39,139  Widening of arterial 
diameters is a dynamic, early response to risk factors and wall thickening.75  Carotid diameters 
are positively related to IMT.112 
All four measures are influenced by hemodynamics within the blood vessels and are 
indicators of vascular aging; and as such, convey different aspects of underlying disease.  Shear 
stress is inversely related to carotid diameter, IMT and plaque,18,19,109,140,141 and positively related 
to FMD.127  An individual’s overall vascular aging profile is determined by age-associated 
endothelial dysfunction, intima media thickening, and other evidence of insult to the vasculature, 
along with risk factor exposure and genetic makeup.59   
Reproducibility and application varies across these ultrasound indicators of subclinical 
disease and vascular health.  Of these measures, IMT is most often employed with frequent 
research application and high clinical potential.  It is easy to assess, highly reproducible and has 
standard cut-points suggesting pre-clinical disease. 1,2,77  Plaque is similarly accessible, with 
good reproducibility.  However, categorization of disease by plaque is less straight forward 
because rupture and erosion are more dependent on composition and vulnerability than on degree 
of stenosis, which is what is captured by ultrasound.100-105  And while the degree of obstruction 
should not be underestimated, it is the stability of the plaque that is most relevant to clinical 
outcomes.   
Diameter measures are harder to compare at the individual level and are likely better 
suited to research evaluations, which use group or holistic comparisons.  Arterial diameters (e.g. 
carotid lumen and interadventitial, baseline brachial) are highly dependent on body size with 
narrower diameters (found in shorter individuals) having greater capacity to dilate and adapt 
relative to larger ones.  Carotid diameter measures are not as widely used as IMT and plaque, 
nonetheless these carotid structures are interdependent and occur both as part of the natural aging 
process and in response to insult or injury.  Brachial artery diameter reproducibility is excellent, 
and while not as high, FMD is a stable and reproducible measure.119,123    
Overall, ultrasound measures of carotid IMT, plaque, lumen diameter and interadventitial 
diameter and brachial artery FMD represent a spectrum of subclinical cardiovascular disease and 
vascular health and aging.  They can be used as surrogate endpoints of disease and are targeted 
for primary prevention.53  They compliment one another by evaluating both the structural (e.g. 
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IMT, plaque) and functional (e.g. FMD) health of the vasculature.48,49  Measures of the 
peripheral arteries are useful research tools for evaluating early systemic atherosclerosis in large 
populations.  Finally, it is worth noting that all of these structures are in constant flux because of 
vascular adaptation, showing both negative and positive progression over time, and reversibility 
with treatment. 
1.4 PUTATIVE RISK MARKERS 
When evaluating cardiovascular risk, consideration of a global risk profile provides better 
predictive power than any single risk factor.72,142  While biological factors are typically 
considered, many other markers have been found to be associated with pre-clinical 
cardiovascular disease and disease outcomes.  Thus, in addition to traditional cardiovascular risk 
factors (e.g. age, blood pressure), certain disease conditions (e.g. inflammatory autoimmune 
disorders, metabolic syndrome) and psychosocial aspects (e.g. hostility, depression, life stress) 
have also been found to be associated with cardiovascular health.  By definition, risk factors are 
neither necessary nor sufficient to cause a disease; however, they are useful indicators for 
determining who is more likely to develop one.143  Additionally, associated risk factors can 
sometimes be targeted for treatment in hopes of helping the overall burden of disease.  
Therefore, additional research into the associations of putative risk markers and measures of 
early atherosclerosis is warranted.  Here we will specifically consider traditional cardiovascular 
measures, rheumatoid arthritis and negative affect as potential precursors and consequences of 
atherosclerosis and vascular health. 
1.4.1 Traditional Cardiovascular Risk Factors 
Traditional cardiovascular risk factors have been extensively examined in conjunction with 
subclinical measures of endothelial dysfunction, atherosclerosis and vascular aging.3-
7,9,39,62,75,78,81-83,107,111-117  In general, several categories of risk factors are typically 
considered.53,71,142,144  These include blood pressure (diagnosis of hypertension or taking 
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antihypertensive medications), lipids (total cholesterol, low density lipoproteins, high density 
lipoproteins, triglycerides, apoprotein B), insulin (glucose, diabetes, anti-diabetic treatment), 
body size (weight, body mass index, waist circumference), smoking/exposure to passive 
smoking, physical activity, aging and gender;  and more recently, menopausal status, lipoprotein 
subfractions, homocysteine, metabolic syndrome and inflammatory markers.42,53,54,142,145,146  For 
example, the Framingham risk score, a common algorithm for assessing 10-year cardiovascular 
disease risk, assesses age, lipid levels, blood pressure, and smoking and diabetes status.147  
Familial predisposition, that is a first-degree relative with early-onset atherosclerotic 
cardiovascular disease, can also be considered as a traditional marker of risk.142  
Because of their high association with cardiovascular disease and their link to unhealthy 
living habits, many of these factors are naturally targeted for lifestyle and behavior 
changes.53,54,148,149  A task force from the American College of Cardiology53 suggests 
consideration of primordial cardiovascular prevention (i.e. the prevention of risk factors).  Thus, 
healthy eating, physical activity, ideal weight and psychosocial factors would be implemented to 
curtail the development of hypertension, diabetes, obesity and hypercholesterolemia.  Primary 
prevention of these latter factors occurs prior to overt disease, but after inflammation, endothelial 
dysfunction, carotid stenosis and coronary calcification have begun.53  Aggressive secondary 
prevention measures, including medication, surgery and rehabilitation, are critical for patients 
with established cardiovascular disease who are at high risk for future events.53,148,150 
1.4.2 Disease Specific Risk – Rheumatoid Arthritis 
Rheumatoid arthritis is a chronic, inflammatory autoimmune disorder that affects 1% of the U.S. 
population, particularly women of childbearing and early menopausal ages.151-155  Patients with 
rheumatoid arthritis have a reduced life expectancy, most commonly attributable to their 
increased incidence of cardiovascular events including, atherosclerosis of the coronary arteries 
and myocardial infarction.156-159  In patients with rheumatoid arthritis, cardiovascular disease is a 
major determinant of morbidity and is the leading cause of death.156-159   
Inflammatory aspects of the disease are of particular interest, given their link with 
cardiovascular disease in the general population and the role of inflammation in both 
atherogenesis and rheumatoid arthritis.91,160-165  While, the relationship between inflammatory 
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markers and atherosclerosis in patients with rheumatoid arthritis has been inconsistent across 
some studies, logical pathways by which systemic inflammation contributes to atherogenesis in 
patients with rheumatoid arthritis have been proposed.166-168   
Other factors associated with rheumatoid arthritis, such as pharmacological treatment, 
disease duration, and swollen joint counts may also be useful for identifying specific aspects of 
rheumatoid arthritis with potential links to atherosclerosis.84,85,161,169  Interestingly, traditional 
cardiovascular risk factors have not been consistently linked with rheumatoid arthritis, 156,158   
although components of the metabolic syndrome show positive associations with IMT170 and 
combining traditional and nontraditional risk factors increases the accuracy of predicting carotid 
plaque.171 
1.4.3 Psychosocial Risk – Negative Affect 
It has long been postulated that negative emotions play a role in the etiology of physical illness.  
Multiple behavioral and physiological pathways have been identified in both human and animal 
research, particularly in studies examining coronary heart disease morbidity and mortality.  
Further, certain psychological traits (e.g. hostility and anger, 172 and possibly depression173) can 
be considered chronic or dispositional rather than episodic or acute; therefore their influence 
could be comparable to the lasting or additive effects of some traditional cardiovascular risk 
factors such as hypertension or obesity.  And just as traditional risk factors play independent and 
overlapping roles in the progression of cardiovascular disease, measures of negative affect can be 
considered individually or as a general disposition.   
Four types of negative affect including, depression, anxiety, anger (specifically, Anger In, 
Anger Out and Trait Anger) and hostility, will be considered here (Chapter 4).  Depressed mood 
can be described as feeling sad, irritable, hopeless and discouraged, as a loss of pleasure or 
interest in usual activities, and as feeling a sense of inadequacy or worthlessness.  Anxiety 
includes physical symptoms such as accelerated heart rate, restlessness, shortness of breath and 
nausea, as well as feeling tense, nervous, fearful, “on edge” and worrisome. Anxiety and 
depression share some of the symptoms of chronic diseases such as fatigue/loss of energy, 
weight loss/gain, feeling shaky, trouble sleeping and diminished ability to concentrate/think.   
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Anger and hostility are commonly linked to Type A personality with exaggerated 
response and high stress being typical covariates.  Hostility reflects a person’s attitudes and 
beliefs and is characterized by a tendency to view the world in a negative, cynical fashion.  
Anger is an emotional state that encompasses generalized distress (ranging from mild annoyance 
to outrage and fury), as well as interpersonal components of anger suppression and expression.  
Martin and colleagues describe the trait anger domain with a 3-factor “ABC” model of anger 
(affect), aggression (behavior) and hostility (cognition).174  Interestingly, it has been suggested 
that the cognitive response, rather than overt behavior, may be the aspects of anger and hostility 
that are most influential in cardiovascular disease. 
Several pathways by which negative emotions influence cardiovascular health have been 
considered.  These include health related behaviors that are typical of individuals with these 
characteristics (e.g. smoking),175-178 poor access to or seeking of medical care,179-182 and the 
occurrence of direct acute or chronic pathophysiological changes.172,183-188  Genetics and 
environmental factors also influence psychosocial disposition.189-193  Finally, cardiovascular 
disease itself is associated with depression and anxiety, particularly after surgical 
procedures.194,195 
1.5 RESULTS AND LIMITATIONS OF EXISTING LITERATURE 
The specific manner in which each of the above types of risk markers are associated with 
subclinical disease and cardiovascular events varies.  Some markers may be causal, others 
exacerbate the disease, and still others may occur in conjunction with or as a result of 
cardiovascular outcomes, or in some combination of these modes.  Following is a review of the 
existing literature on the three topics of interest including, traditional cardiovascular risk factors 
and segment-specific IMT, rheumatoid arthritis and subclinical outcomes, and measures of 
negative affect and FMD. 
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1.5.1 Traditional Cardiovascular Risk Factors and Segment-Specific IMT 
Both similar and unique associations have been reported between cardiovascular risk factors and 
the common, internal and bifurcation segments of the carotid artery.  Similarities across 
segments seem natural given the proximity of the segments along the vessel.  However, 
variations in blood flow and sheer stress experienced by each arterial segment could provide 
distinct predisposing factors.  Likewise, differences in cellular processes and the risk factors 
themselves suggest unique associations.  
Some studies have generally found the three carotid segments similarly associated with 
cardiovascular risk factors.10,11,13  Previously published studies have reported positive 
associations of age, male sex, systolic blood pressure, body composition, and smoking with IMT 
of the common and bifurcation areas.10,11,13  Associations with lipids, while not as common, have 
also been reported such that higher low density lipoproteins and lower high density lipoproteins 
have been associated with higher IMT in all three segments.9,11,13  It is possible that examining 
more diseased populations may have made it harder for these studies to tease out any unique 
associations that may exist. 
The level of IMT in the common carotid artery, which is typically more than the internal 
carotid artery but less than the bifurcation area, is partly due to the lower sheer wall force18,19,32 
that is consistent with the laminar blood flow33 in this location.  In terms of risk factors, a 
positive relationship is commonly found between body size and atherosclerosis in the common 
carotid artery.34  Diabetes, which is associated with obesity, is thought to decrease wall shear 
stress and is positively associated with common carotid artery IMT.35  Aging is also inversely 
related to shear stress32 and shows a positive relationship with common carotid artery wall 
thickness. 3,11,13,32  The common carotid artery segment, which is easily and reliably viewed via 
ultrasound, is the most frequently evaluated, and studies of general IMT often report results only 
on this segment. 
In the internal carotid artery segment, the smaller wall thickness, relative to the other 
segments, is likely attributable to the mix of laminar and oscillatory shear stress around the 
arterial wall.19  Infiltration of lipids during extended contact of blood with the wall has been 
linked to areas of low shear stress,36 which portions of this segment experience.  Additionally, 
shear stress influences cellular processes such as an increase in growth-regulatory factors,16,22 
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expression of inflammatory molecules24 and response of pro-oxidant processes,33 which have 
also been linked to low density lipoproteins and atherosclerosis,37,38 although not specifically to 
the internal carotid artery segment.   
The bifurcation, which connects the common carotid artery and internal carotid artery 
segments, is likely influenced by factors related to each of these sites.  The bifurcation 
experiences the most oscillatory stress and turbulence as a result of reverse flow velocity 
components occurring during pulsatile flow.19,32,33  Consequentially, the bifurcation may exhibit 
greater wall thickness and be associated with higher systolic blood pressure.  Higher IMT in the 
bifurcation area may also be a function of plaque, which is commonly found in this location.39  
The influence of shear stress on the extracellular factors of hypertension such as increased 
pressure,16 decreases in vasoactive agents17 and inflammatory effects,14 would have the largest 
impact on the bifurcation segment.  Research on increased residence time of blood36 and 
adherence of platelets and macrophages to the arterial wall,40 which influence lipid infiltration 
and plaque formation, is consistent with associations between lipids and bifurcation IMT.11,13  
The increased residence time might also make the bifurcation more susceptible to the toxic 
components of cigarette smoke.15 
Variations in methodology, including use of older subjects or heart clinic patients, make 
others’ results of IMT by carotid segment challenging to appraise.8-13  Further, previous studies 
have not evaluated the segments in the same statistical model, so associations can not be directly 
compared and tested.  Thus, examining IMT locations in healthy subjects using a repeated 
measures analytic model should provide more definitive results regarding segment-specific 
associations with risk factors. 
1.5.2 Rheumatoid Arthritis and Subclinical Outcome Measures  
Carotid ultrasound findings comparing subjects with rheumatoid arthritis to controls have been 
somewhat inconsistent.  While studies typically find common carotid IMT to be higher in 
patients with rheumatoid arthritis compared to controls,84-89,95 several studies have found no 
difference90-92,99 or the opposite result.94  In regards to carotid plaque, several studies have 
reported no difference in plaque prevalence,84-86,89,91 while others have found increased carotid 
plaque in patients with RA.88,90,92,94,95,97  Further, in examining patients with rheumatoid arthritis, 
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research on associations between markers of inflammation and other measures of rheumatoid 
arthritis severity and atherosclerosis are not clear cut.85-87,89,91,95,160,161,171,196,197  Choice of study 
population, disease-specific influences and/or vascular adaptation may explain these 
inconsistencies in the literature. 
Several studies have described increased IMT in patients with rheumatoid arthritis when 
compared to controls,84-89,95 while others have found no difference,90-92 or lower IMT in patients 
with rheumatoid arthritis.94  Given the high prevalence of cardiovascular morbidity and mortality 
in patients with rheumatoid arthritis, reports of higher common carotid wall thickness in patients 
would be expected.  However, a large study of rheumatoid arthritis men and women found no 
difference in carotid IMT compared with controls.91,92  Similarly, no difference in IMT was 
reported between women with rheumatoid arthritis, women with systemic lupus erythematosus, 
and controls.92  Interestingly, patients with lupus had larger carotid artery diameters than 
controls.  In a small Italian study, internal carotid IMT was higher in patients with rheumatoid 
arthritis, while common carotid IMT was similar to controls.90   
Differences in study populations (rheumatoid arthritis and controls) may explain some of 
the discrepancies in IMT results, given variations in age and gender of subjects.  Research 
indicates that IMT increases with age,75,198 with menopausal status independent of age,146 and is 
greater in men.4  Average age of subjects was 55 years old in three studies that report greater 
IMT in patients with rheumatoid arthritis compared to controls.84-86  In contrast, in studies where 
the average age was less than 50 or greater than 60 years old, IMT was higher in controls or did 
not differ between groups.91,92,94  Taken together, these results suggest a curvilinear relationship, 
where IMT is similar between patients and controls at younger and older ages.  Ethnicity and 
control characteristics may also be influencing results given that those that found greater IMT in 
patients with rheumatoid arthritis all occurred outside the United States, while the others were 
US-based and comprised primarily of Caucasians.   
With a closer look at the discrepancies between previously published studies, the 
apparent contradiction in IMT results may in fact be mediated by differences in stage of arterial 
remodeling.  Changes in vessel hemodynamics (primarily wall shear stress)63,74,75,108-110  initiates 
arterial dilatation, which allows lumen cross-sectional area to be kept constant and maintains or 
decreases IMT by distributing it over a larger area.  However, the artery has a limited capacity to 
dilate,73,74,199 and further increase in IMT and plaque progression will prevail.  In other words, 
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the lack of association between rheumatoid arthritis and IMT may be a function of the stage of 
vascular remodeling, whereby younger rheumatoid arthritis samples92 may be at an earlier stage 
of atherogenesis (prior to differences in IMT), while older samples91 may be at the final stages of 
remodeling (thus showing greater IMT than controls).  Then with continued aging, 
cardiovascular disease morbidity and mortality may be influencing results such that patients with 
severe rheumatoid arthritis are not able to participate in research.  Interestingly, a study of IMT 
progression93 in women with rheumatoid arthritis found an accelerated rate of annual wall 
thickening when compared to healthy controls.  Thus, while there is evidence that IMT may 
differ between patients with rheumatoid arthritis and controls, the course of progression may be 
distinct from other conditions where increased IMT is seen at a very early stage of atherogenesis.   
Alternatively, a unique, rheumatoid arthritis-related modification of atherogenesis may 
exist.  Perhaps the underlying autoimmune disease process, its treatment, or an interaction 
between the two may account for a change in the evolution of atherosclerotic vascular disease in 
these patients.  In other words, the subclinical atherosclerosis found in several studies may not 
reflect the typical interplay between diameters and IMT as just described.   
The association between prevalence of plaque and rheumatoid arthritis similarly remains 
unresolved.  Patients with rheumatoid arthritis were more likely to have carotid plaque than 
controls in a recent study of arterial stiffness,92 and in a study examining the role of insulin 
resistance in atherosclerosis.88  Another small preliminary study90 found patients with 
rheumatoid arthritis had a higher stenosis/IMT score in the internal carotid artery than controls.  
Conversely, several previous investigations have found prevalence of plaque to be similar in 
patients with rheumatoid arthritis and controls.84-86,89,91  Plaque frequently occurs in areas of 
transition or turbulence (e.g. internal carotid or carotid bifurcation) within the artery,110 therefore 
variations in methodology across studies (i.e. area of plaque assessment within the carotid artery) 
may be influencing results.   
Inflammatory markers, which are inherent to autoimmune diseases such as rheumatoid 
arthritis and systemic lupus, have been examined as potential factors in promoting 
atherosclerosis.91,160,161,200  The pathogenesis of rheumatoid arthritis includes multiple 
proinflammatory agents including cytokines (e.g. tumor necrosis factor alpha and interleukin 1), 
chemokines and adhesion molecules, as well as active angiogenesis, which provides oxygen and 
nutrients needed for inflammatory cell recruitment.152  Nonetheless, studies examining specific 
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markers have not consistently found associations with IMT and/or plaque.  C-reactive protein 
was not significantly related to carotid IMT in one study,85 while others found a positive 
association between C-reactive protein and IMT and plaque,91 and between maximum C-reactive 
protein values and carotid IMT.166  A positive association between soluble intercellular adhesion 
molecule and IMT and between soluble endothelial adhesion molecule and plaque have each 
been reported.161  Increased erythrocyte sedimentation rate, a marker of systemic inflammation, 
was associated with increased IMT independent of other risk factors in some studies91,160 but not 
others.85 Interestingly, a study of 63 women with rheumatoid arthritis found a positive 
association with progression of IMT and markers of inflammation, such as C-reactive protein, 
white blood cell, platelet counts and erythrocyte sedimentation rate, which suggest that change in 
atherosclerosis rather than initiation of wall thickness may the link.93  Nonetheless, inflammation 
in rheumatoid arthritis has been consistently associated with endothelial function,166,201 one of 
the earliest markers of atherosclerosis, and initiating pathways by which systemic inflammation 
contributes to atherogenesis in patients with rheumatoid arthritis are quite likely (as reviewed by 
166-168).   
Other factors characteristic of patients with rheumatoid arthritis and indicative of disease 
severity and activity are also important.  A positive association between duration of disease and 
IMT has consistently been reported.85,86,95,171,196,197  Research on pharmacological treatment is 
mixed, showing that glucocorticoids and disease-modifying antirheumatic drugs may be 
positively 169 or negatively 161 associated with atherosclerosis and cardiovascular mortality.202  
These incongruencies are possible because treatment can be interpreted as a marker for 
rheumatoid arthritis severity, contributing adversely to cardiovascular risk factors (e.g. 
hypertension) or conversely, exerting a protective effect by reducing rheumatoid arthritis-related 
systemic inflammation.98,163,203-205  Class, type, effectiveness and side effects of medications 
influence when and how they are prescribed, consequently affecting their associations with 
atherosclerosis.  Successful long-term management requires frequent assessment of disease 
activity and response to treatment.152,206  Further, the overall therapeutic approach to rheumatoid 
arthritis treatment has changed overtime, where disease-modifying antirheumatic drugs, such as 
methotrexate, are now given earlier rather than later in the course of disease, and development of 
more effective therapies is a continual process.152,206,207  Additionally, studies vary on whether 
current, cumulative, or multiple medication exposure is considered.  Typical measures of disease 
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severity, such as swollen joint counts, Health Assessment Questionnaire208 scores and disease 
activity have also revealed inconsistent results with some investigators showing independent 
positive associations with IMT,85,88 and others finding no association between these markers and 
measures of subclinical atherosclerosis.84  More recently, other disease aspects, such as 
hypothyroidism and uric acid concentrations, have been considered in relation to 
atherosclerosis.171,196   
In sum, using IMT and plaque prevalence as measures for providing insight into the 
increased cardiovascular disease experienced by patients with rheumatoid arthritis needs further 
investigation.  Additionally, carotid ultrasound studies of patients with rheumatoid arthritis thus 
far have not included outcome measures of lumen or interadventitial diameter.  Mixed findings 
on the association of carotid atherosclerosis with inflammatory markers and related indicators of 
rheumatoid arthritis severity and activity also warrant further exploration.  Our study will 
provide insight into vascular adaptation in women with rheumatoid arthritis by looking at carotid 
diameters in addition to IMT and plaque.  Associations between indicators of rheumatoid 
arthritis disease, including inflammatory markers, and carotid outcomes will also be examined. 
1.5.3 Negative Affect and Subclinical Cardiovascular Disease 
There is good evidence linking negative affect and cardiovascular disease (reviewed by 184-187), 
whether clinical events55,57,209-215 or subclinical outcomes214-220 are examined.  Psychosocial traits 
and stressors influence cardiovascular disease via both behavioral and pathophysiological 
pathways.184-187,188  Measures of negative affect, such as hostility, anger, anxiety and depression 
are of particular interest given previous associations found with subclinical cardiovascular 
disease.  While associations with IMT have been studied extensively, examining negative affect 
and endothelial function has been done in a limited number of studies, several with small sample 
sizes.221-224  Further, previous studies of brachial vasodilatation have primarily examined 
depression,221-223,225 with one considering hostility in conjunction with induced stress,224 and only 
one study looking at multiple psychosocial clusters.128  Thus, further investigation regarding 
associations between FMD and several types of negative affect in a sizable sample of both men 
and women is warranted. 
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Studies of major depressive episodes or previously measured depression have more 
consistently found associations with measures of subclinical cardiovascular disease than studies 
examining depressive symptoms.226-228 Research on the sample to be used here found depressive 
symptoms at baseline associated with three-year progression of IMT, but not IMT at 
baseline.228,229  Other measures of subclinical cardiovascular disease (e.g. IMT & coronary 
calcification) also have a reported link with a history of two or more major depression episodes, 
but not with depressive symptoms.226,227  Nonetheless, depressive symptoms are consistently 
reported after clinical cardiac procedures and events.194,195 
Of particular interest here, is the association between depression and early endothelial 
dysfunction via FMD, which a few studies have examined.128,221-223,225  A study of 
postmenopausal women looking at a cluster of multiple measures of negative affect reported a 
negative association between FMD and an anxiety/depression factor measured several years 
prior.128  However, results of the individual scales showed that Trait Anxiety and Anger In (i.e. 
anger suppression), and not depression or social support, were the measures of the 
anxiety/depression cluster that were specifically associated with smaller diameter change.  In 
three small studies (n < 39), impaired vasodilatation was associated with concurrent clinical 
depression or a history of major depression.221-223  While another study found and inverse 
relationship between high depressive symptoms (perhaps more indicative of chronic depression) 
and FMD.225   
While depression and anxiety are considered similar constructs in terms of their influence 
on chronic disease,173,187 results from studies looking specifically at anxiety and subclinical 
measures of cardiovascular disease have been mixed.  Sustained anxiety was positively 
associated with IMT progression in one study,219 but Trait Anxiety and general anxiety were not 
in others,218 including our own.228,229  As mentioned earlier, Harris and colleagues found the 
anxiety component of a depression/anxiety cluster was associated with smaller brachial artery 
diameter change.128   
Measures of anger and hostility have been positively associated with carotid artery 
IMT214,215,217 and IMT progression213,216,218,220 as well as cardiovascular risk factors and 
events,209-211,214-216 including mortality.212,213  In terms of endothelial-dependent vasodilatation, 
Harris and colleagues128 found an inverse association with an aggregate Anger/Type A factor 
measured approximately 14 years prior to the women becoming postmenopausal.  Individual 
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scales of Trait Anger and Type A personality, as well as Anger In, were associated with smaller 
diameter change, predominantly among non-hormone therapy users.  A small study (n=38) 
looking at the effects of mental stress in both sexes found an inverse association between hostile 
affect and FMD.224  It is not known whether the relationship between anger and/or hostility with 
FMD holds true for a larger sample of men and women, or when multiple psychosocial 
symptoms are measured closer in time, thus research addressing these concerns would be 
informative. 
It’s generally concluded that psychosocial traits and stressors influence cardiovascular 
disease via both pathophysiological and behavioral pathways.184-187  Pathophysiological 
mechanisms include greater platelet activation,230 cardiovascular reactivity (including increases 
in blood pressure and heart rate),231 inflammation,232,233 and excessive sympathetic nervous 
system and hypothalamic-pituitary-adrenal axis activity (as indexed by greater norepinephrine 
and plasma cortisol).231,234  In particular, inhibition of cortisol improves FMD in depressed 
patients.235  Substantial overlap exists in the biologic and functional pathways underlying these 
mechanisms and thus, many of these processes may be different manifestations of the same 
etiology.  Pathways of the vascular endothelium, which is the measure of vascular health 
evaluated in our study, have been outlined by Harris and Matthews188 and suggest mechanisms 
similar to those implicated in other studies.  Further, genetic factors also contribute to 
psychosocial disposition,189 and thus likely reflect intrinsic influences on associations between 
negative affect and cardiovascular disease.  Even so, results are inconclusive on whether 
improvements are seen when psychosocial treatments are added to standard cardiovascular 
rehabilitation (e.g. 236,237).   
Negative affect has also been linked to adverse health habits, behavioral components of 
medical care, and environmental factors.  Unhealthy behaviors linked to negative emotions 
include poor sleep, increased alcohol use, smoking, obesity and poor diet.175-178,192 Individuals 
with negative dispositions are also less likely to seek or have access to medical care, and to 
adhere to medical interventions.179-182  While it is not clear whether negative emotions mediate 
the association between social economic status and health,192,193 individuals from lower and 
higher statuses clearly differ in how they describe their social environment and interactions with 
others.238-240  Familial and twin studies suggest that both genetic and non-shared environmental 
factors influence negative affect.189-191   
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It can not be said with certainty whether insult to the vascular system or psychosocial 
traits occurs first since genetic and environmental predispositions underlie both; but the 
conditions appear to be fundamentally linked.  Behavioral factors are highly influential,175 but do 
not solely account for associations between psychosocial traits and cardiovascular disease; and 
psychosocial influences are evident even after controlling for traditional cardiovascular risk 
factors.211,216 217  Further, the INTERHEART study, which included nearly thirty-thousand 
subjects from fifty-two countries, found a psychosocial factor on par with traditional 
cardiovascular risk factors in terms of population attributable risk for myocardial infarction.55,57  
The influence of negative affect is apparent in both healthy and diseased populations, with 
results more consistent in healthy ones.173  Examining associations in healthy individuals 
supports the notion of non-traditional risk factors influencing cardiovascular health and 
minimizes confounding effects of cardiovascular symptoms and disease, which impact affect. 
In sum, our study proposes to examine associations between negative affect and 
subclinical disease in healthy individuals.  We will extend findings of previous FMD studies, 
which in the aggregate, have been limited by small sample sizes, the inclusion of only a single 
gender, and/or use of a single predictor, primarily evaluating depression.  Further, by examining 
healthy participants, who have not shown clinical signs of cardiovascular disease, we can 
postulate that the connection is unlikely to be biased by knowledge of poor health or traditional 
cardiovascular risk factors. 
1.6 HYPOTHESES AND SPECIFIC AIMS 
Influences on early atherosclerotic disease will be explored via associations between ultrasound 
findings and putative markers of risk.  Specifically, hypotheses will focus on traditional 
cardiovascular risk factors, diagnosis and indictors of rheumatoid arthritis, and measures of 
negative affect in conjunction with segment-specific IMT, carotid outcomes and FMD, 
respectively. 
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1.6.1 Traditional Risk Factors and Segment-Specific IMT 
First, it is hypothesized that considering traditional cardiovascular risk factors in conjunction 
with individual segments of IMT may provide better insight into the mechanisms of 
atherosclerotic development than looking at associations with overall IMT (average or maximum 
IMT), as is commonly done when examining associations with markers of risk.71  Variations in 
cellar processes and hemodynamics throughout the vessel, as well as distinctions in the risk 
factors themselves, provide the rational for looking at segments separately.   
While the associations between segment-specific carotid IMT and traditional 
cardiovascular risk factors have been explored in a handful of populations, additional research is 
needed.  Specifically, investigating risk factor associations with all three segments in the same 
statistical model has not previously been done.  Further, associations will be considered in a 
healthy sample without clinical signs of cardiovascular disease.  It is suspected that each IMT 
segment will be differentially associated with individual traditional cardiovascular risk factors.   
Thus, the purpose of the first report (Chapter 2) is to evaluate atherosclerotic risk factors 
and IMT by carotid artery segment in a sample of 453 healthy women aged 46-58 years.  In 
addition to using standard linear regression models, a repeated measures model is used to 
provide evidence of segment-specific pathways for development of IMT while accounting for the 
interdependence of IMT measures within each woman. 
1.6.2 Rheumatoid Arthritis and Carotid Outcomes  
Second, it is hypothesized that middle-aged women with rheumatoid arthritis will have a higher 
burden of atherosclerotic carotid disease as indicated by IMT, plaque and arterial diameters, 
independent of traditional risk factors for cardiovascular disease, and that rheumatoid arthritis-
related factors will be independently associated with these ultrasound indicators of carotid 
atherosclerosis.  We also have reason to believe that simultaneously examining carotid IMT, 
plaque, and diameters may provide new insight into evidence of preclinical atherosclerosis and 
vascular aging in patients with rheumatoid arthritis.   
The reason is unclear as to why IMT of the carotid arteries in patients with rheumatoid 
arthritis has been found to be higher than matched controls in many but not all studies.84-86,89-93  
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Given that IMT, plaque and diameters are interdependent,74,75,241,242 it is possible that the stage of 
atherosclerotic development and vascular aging should be considered.  Perhaps arterial dilatation 
in patients with rheumatoid arthritis is initially maintaining their level of IMT, and hence varying 
results are reported across studies.  We look to support this theory by including lumen and 
interadventitial diameters, as well as IMT and plaque prevalence, as outcome measures.   
Additionally, it is posited that the carotid measures will be associated with inflammatory 
markers and related indicators of rheumatoid arthritis severity and activity.  Women who 
participated in the cardiovascular rheumatoid arthritis study were well characterized, thus a 
variety of rheumatoid arthritis features will be examined, including phlebotomy/laboratory 
measures, medication use and disease-specific measures.   
Thus there are two aims of the second study (Chapter 3).  We plan to compare carotid 
IMT, plaque and arterial diameters in 93 middle-aged women with rheumatoid arthritis to 93 
healthy women matched for age, race and menopausal status.  The second purpose is to evaluate 
rheumatoid arthritis-related factors, including inflammatory markers, in patients with rheumatoid 
arthritis for an association with early indicators of carotid disease. 
1.6.3 Negative Affect and Flow-Mediated Dilation 
Third, it is hypothesized that measures of anger, hostility, anxiety and depression will be 
negatively associated with FMD.  We propose to add to the literature on FMD and psychosocial 
traits by looking at associations between multiple measures of negative affect and FMD in both 
men and women.   
There is no definitive answer on how negative affect is linked to cardiovascular disease 
and if one might precede the other.  Nonetheless, studying generally healthy individuals implies 
that the connection is unlikely to be biased by knowledge of overt disease.  Further, given that 
endothelial dysfunction occurs very early in the cardiovascular disease continuum, some 
knowledge can be gained by looking at associations with brachial artery FMD, rather than IMT 
as is frequently done.   
The purpose of the third study (Chapter 4) is to examine whether a link exists between 
negative psychosocial indices and brachial artery vasodilatation in 332 healthy older men and 
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women.  Specifically, we plan to evaluate if depression, anxiety, anger and hostility are 
associated with FMD, while controlling for traditional cardiovascular risk factors. 
1.6.4 Specific Aims  
In sum, the objective of my dissertation is to examine associations between measures of 
atherosclerosis and vascular health with putative risk markers.  My dissertation will address the 
following three specific aims: 
1. Evaluate the extent to which IMT locations within the carotid artery will be differentially 
associated with traditional cardiovascular risk factors. 
2. Assess whether diagnosis of rheumatoid arthritis and indicators of the disease will be 
associated with measures of carotid atherosclerosis and vascular health. 
3. Identify measures of negative affect inversely associated with endothelial-dependent 
FMD of the brachial artery in both men and women. 
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2.1 ABSTRACT 
Objective:  We investigated associations between segment-specific carotid intima medial 
thickness (IMT) and cardiovascular risk factors collected prior to menopause for insight into 
mechanisms of atherosclerosis development.  
Methods and Results:  Participants were 453 healthy women (aged 46-58 years) enrolled 
in a dietary and physical activity randomized clinical trial.  Ultrasound scan measures were taken 
approximately 2.7 years after baseline in the common (CCA), bifurcation (bulb) and internal 
(ICA) carotid artery segments.  When scanned, 84% remained premenopausal.  In linear 
regression models, adjusted for age, menopausal status and intervention group, measures 
independently (p<.05) and positively associated were: baseline weight (β=0.007 per 5 kg), SBP 
(β=0.008 per 10 mmHg) and age (β=0.02 per 5 years) with CCA IMT; smoking (β=0.08), weight 
(β=0.009) and SBP (β=0.02) with bulb IMT; and apoprotein B (β=0.01 per 0.1 g/L) with ICA 
IMT.  Differential effects in a repeated measures model with all three IMT locations showed 
these risk factors to have segment-specific positive associations.  The effect of weight was 
strongest in the CCA, smoking and SBP were specific to the bulb and apoprotein B was strongest 
in the ICA segment.   
Conclusion:  Analyses indicate that cardiovascular risk factors may differentially affect 
IMT in the CCA, bulb and ICA segments of healthy middle-aged women.  
Key Words:  atherosclerosis, women, carotid artery, ultrasound, cardiovascular risk 
factors 
 
2.2 INTRODUCTION 
Carotid intima medial thickness (IMT) is considered a marker of early atherosclerosis, predicts 
future risk of cardiovascular disease, and has been found to be high in individuals with coronary 
heart disease and myocardial infarction (IMT ≥ 0.73 mm and ≥ 1 mm, respectively).1;2  Among 
women of all ages, cardiovascular risk factors, such as high blood pressure, body mass index and 
cholesterol, are associated with average and maximum carotid IMT.3-7  However, associations 
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with specific locations of thickening within the carotid artery are not as definitive.8-13  
Considering risk factors in conjunction with specific segments of IMT may provide better insight 
into the mechanism of atherosclerotic development.  It is likely that differences in 
hemodynamics, cellular processes, and the risk factors themselves affect the development and 
progression of disease.14-22  Additionally, each site may have its own predisposing factors12;19 
and biomechanical and biochemical pathways16;20;23;24 may be acting in combination to influence 
atherosclerosis.   
The purpose of this report is to evaluate atherosclerotic risk factors and IMT by carotid 
artery segment in a sample of 453 healthy women age 46-58 years.  In addition to using standard 
linear regression models, we use a repeated measures model to provide evidence of segment-
specific pathways for development of IMT.  Investigating risk factor associations with all three 
segments in the same model has not been done in previous studies 
2.3 METHODS 
2.3.1 Participants 
Participants were recruited from the 535 women (92% Caucasian) who participated in the 
Women’s Healthy Lifestyle Project, an intervention trial designed to evaluate the efficacy of diet 
and physical activity in preventing weight gain and elevations in other cardiovascular risk 
factors.25-27  Women were enrolled from 1992-1994, randomized to either lifestyle intervention 
or an assessment-only control, and followed over 54 months.  Beginning in 1994, carotid 
ultrasound scans were offered to all participants and obtained in 453 women (85%).   
To be eligible for enrollment, women had to be aged 44-50 years, pre-menopausal 
(defined as less than three months amenorrhea in the six months prior to the screening interview) 
and have a diastolic blood pressure (DBP) < 95 mmHg, body mass index (BMI) between 10 and 
34, fasting glucose < 7.77 mmol, low density lipoproteins (LDL) between 2.07 and 4.14 mmol 
and total cholesterol between 3.26 and 6.72 mmol.  Exclusion criteria included hysterectomy, 
hormone therapy, and use of anti-hypertensive, lipid-lowering, insulin, thyroid or psychotropic 
medications.  Further details of the clinical trial are available in previously published articles.25-27   
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Both the clinical trial and the carotid exams were approved annually by the Institutional 
Review Board of the University of Pittsburgh.  All participants provided written consent.   
2.3.2 Clinical Measures 
Baseline clinical measures included: systolic blood pressure (SBP), DBP, weight, BMI (kg/m2), 
waist circumference, percent body fat (from dual energy x-ray absorptiometry scanner) and 
fasting total cholesterol, high density lipoproteins (HDL), HDL2, HDL3, LDL, triglycerides, 
apoprotein B and glucose.  Dietary intake (kilocalories per day) was assessed by questionnaire.28  
Leisure time physical activity (kilocalories in the past week) was measured by interview.29  
Serum insulin was assessed at the 6-month follow-up visit rather than baseline.  Standard 
enzymatic assays were used to measure total serum cholesterol, HDLs, triglycerides and glucose; 
LDL was estimated by the Friedewald equation; apoprotein B was determined via turbidimetric 
measurement; and serum insulin was determined by radioimmunoassay.  Smoking was 
categorized as current, former or never.  Additional details of the clinical measures are available 
in previous publications.25-27  
At each follow-up visit and at the time of their scan, women were assessed for hormone 
therapy use (any in the prior year) and hysterectomy, and categorized as pre-, peri- or 
postmenopausal (perimenopausal = missing a bleeding cycle or taking hormone therapy for 3-11 
cycles in the last year; postmenopausal = no bleeding cycle or taking hormone therapy for ≥12 
consecutive cycles, or hysterectomy).  Since most women remained premenopausal at scan time, 
menopausal status was dichotomized as premenopausal versus peri/post menopausal for 
analyses.   
2.3.3 Carotid Ultrasound Measures 
Carotid arteries were examined using an ultrasound scanner (Toshiba SSA-270A, Tustin, CA) 
equipped with a 5-MHz linear array imaging probe.  With participant in supine position, arteries 
were viewed in transverse and longitudinal projections.  For the common carotid artery (CCA) 
segment, both near and far walls were examined 2 cm proximal to the bifurcation (bulb).  For the 
bulb area and internal carotid artery (ICA), measurements were taken of the far walls only (since 
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near walls cannot be consistently visualized).  Digitized images were used to trace the medial-
adventitial and intima-lumen interfaces across 1-cm lengths and compute IMT for each 
segment..30 Average IMT was calculated from the mean of both the right and left carotid arteries 
of the three segments (8 locations total). 
Our IMT reliability study (n=15)30 reported correlation coefficients of 0.96 between 
sonographers and 0.99 between readers for average IMT, and was greater than 0.87 for 
individual segments across sonographers and readers. 
2.3.4 Statistical Analysis 
Descriptive measures are summarized as mean ± standard deviation unless otherwise noted.  
Intervention and control groups were compared using standard t-tests, Wilcoxon tests and chi-
square tests.  Analyses are reported on the pooled population, given that risk factors were 
collected prior to the intervention and to maximize available data.   
Pearson correlation coefficients were calculated between normally distributed 
cardiovascular risk factors and each IMT measure.  Spearman correlations were calculated for 
non-normal risk factors.  To determine which traditional cardiovascular risk factors were 
independently associated with each IMT segment, variables with a p-value of ≤ 0.15 in 
univariate correlations were included in multivariable linear regression models.  More 
parsimonious multivariable models were identified with a stepwise selection procedure, using p 
< 0.05 as the selection cutoff.  Models were adjusted for age, intervention group and menopausal 
status at the time of the scan.  The three segment models (i.e. CCA, bulb and ICA) suggested that 
risk factor associations with IMT varied according to the IMT measurement location. 
To formally test these observed differences, a single model utilizing all three IMT 
measures was developed.  Since the three IMT measures taken from each woman were not 
independent, a repeated measures model was used.  This modeled each IMT value (i.e. 3 lines of 
data per person; one for CCA IMT, one for bulb IMT, and one for ICA IMT) as a function of risk 
factors and a 3-level variable indicating location.  The correlation between each woman’s IMT 
values, which is accounted for in the repeated measures model, was modeled using a compound 
symmetric correlational structure.31  Covariates in the repeated measures model included all 
significant multivariable regression predictors, IMT measurement location, and examined 
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possible location by risk factor interaction effects.  Significant interaction effects would signify 
segment-specific effects.  All analyses were implemented using the SAS system for windows 
version 8.2 (SAS Institute, Cary, NC). 
2.4 RESULTS 
The women scanned were similar in clinical characteristics to those not scanned (data not 
shown).  Clinical characteristics for the 453 participants are presented in Table 2-1 and were 
similar across control and intervention groups. 
Scans were done approximately 2.7 years (range 0.7-7.6 years) after the baseline visit, 
when 84% of all subjects were still premenopausal.  There were no significant differences in 
IMT measures between treatment groups, thus the groups were combined for remaining analyses 
(Table 2-2).  Mean average IMT was 0.68 mm in the pooled group; IMT was highest in the bulb 
and lowest in the ICA segment.  For each measure, results include only participants for whom 
both the right- and left-sided IMT measurement was available.  Those with missing IMT (n=9) 
were similar in available data to those included (data not shown). 
2.4.1 Univariate Associations 
In unadjusted correlations, average IMT was positively and significantly (p < 0.15) associated 
with typical cardiovascular risk factors of age, weight, BMI, waist circumference, percent body 
fat, SBP, DBP, lipid measures (i.e. cholesterol, LDL, apoprotein B and triglycerides), insulin and 
physical activity; while HDL and HDL 2 showed a negative association.  Examining arterial 
segments individually, IMT at all three locations was positively associated with baseline weight, 
BMI and waist circumference.  Additionally, higher CCA IMT was associated with older age and 
higher SBP, DBP, percent body fat, apoprotein B and insulin; higher bulb IMT was associated 
with higher SBP, DBP, percent body fat, lipid measures, insulin and physical activity, and lower 
HDL and HDL2; and higher ICA IMT was associated with older age, higher lipid measures and 
insulin and lower HDL.  In unadjusted bivariate analyses, significant positive associations were 
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found between average IMT and smoking, hormone therapy and hysterectomy.  By segment, 
significant positive associations were found between CCA IMT and smoking, hormone therapy 
and hysterectomy, and between bulb IMT and smoking.  Correlations between IMT across the 
three locations were moderate (range r=0.32 to 0.43).   
 
 
Table 2-1: Participant Characteristics (n=453)* 
Characteristics at Baseline     
Age (years) 46.9 ± 1.9  HDL3 (mmol/L) 1.23 ± 0.22 
Weight (kg) 67.3 ± 9.9  LDL (mmol/L) 2.97 ± 0.57 
BMI (kg/m2) 25.1 ± 3.3  Apoprotein B (g/L) 0.74 ± 0.16 
Waist Circumference (cm) 78.5 ± 8.5  Triglycerides (mmol/L)† 0.80 [0.60-1.10] 
Body Fat (%) 33.1 ± 4.6  Glucose (mmol/L) 5.4 ± 0.4 
Systolic BP (mmHg) 110.3 ± 12.7  Insulin (pmol/L)‡  99.8 ± 54.8 
Diastolic BP (mmHg) 68.2 ± 8.2  Dietary Intake (kcal/day) 904 [504-1817] 
Cholesterol  (mmol/L) 4.90 ± 0.63  Physical Activity (kcal/wk) 0 [0-805] 
HDL (mmol/L) 1.53 ± 0.33  Smoking: Current  44 (9.8) 
HDL2 (mmol/L) 0.28 ± 0.16                  Former 175 (39.1) 
     
Characteristics at the Time of the Scan    
Peri/Post Menopausal 74 (16.4)  Hormone Therapy Use 94 (20.8) 
Hysterectomy 14 (3.1)  Time Since Baseline (yrs) 2.7 ± 1.1 
* Characteristics are summarized as mean ± standard deviation, median [inter-quartile range] or 
number (percentage).  BMI=body mass index, BP= blood pressure, HDL=high density 
lipoproteins, LDL=low density lipoproteins.  
† Triglycerides differed between control (0.75 [0.58-1.05]) and intervention (0.87 [0.62-1.13]) 
groups (p=0.02). 
‡ Insulin was measured at 6 months after the baseline visit. 
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2.4.2 Multivariate Associations 
Linear regression models were adjusted for intervention group, age and menopausal status at 
scan time.  Risk factors showing significant univariate correlations with IMT (listed above) were 
included in respective models for average IMT and each location.  Significant independent 
predictors of greater average IMT were higher weight, SBP, age and current smoking (Table 2-
3).  Higher weight, SBP, age and hysterectomy were independently associated with higher CCA 
IMT.  Current smoking, weight and SBP were positively associated with bulb IMT.  Higher 
apoprotein B was associated with higher ICA IMT.  Comparing individual covariate percents of 
variation in each model (i.e. adjusted R2) it was evident that weight was the largest contributor to 
average and CCA IMT, SBP was most prominent for bulb IMT and apoprotein B nearly the sole 
contributor to ICA IMT; Additionally, age at scan was 1.03% and 1.34% of the “other” category 
for average and CCA IMT, respectively (Figure 2-1). 
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CCA=common carotid artery, bulb=bifurcation, ICA=internal carotid artery 
*Other=Intervention group, peri/postmenopausal status and age at scan for IMT locations, 
except CCA IMT for which hysterectomy is also included in the other variance  
 
Figure 2-1: Percent of Variation in IMT in Average and Arterial Segments 
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Thus, differential effects could be seen across arterial locations.  For example, a 10mmHg 
increase in SBP would produce a 0.008 mm increase in CCA IMT, a 0.022 mm increase in bulb 
IMT and no significant change in ICA IMT, although these comparisons do not take into account 
variations in wall thickness.  To test the statistical significance of these observed differences, a 
single repeated measures linear model utilizing all three IMT measures (thus accounting for 
within woman and between women variability in IMT) was used to examine segment-specific 
associations.   
2.4.3 Repeated Measures 
The repeated measures model included significant multivariable predictors from the previous 
models (weight, SBP, smoking, apoprotein B and hysterectomy), control variables (intervention 
group, menopausal status and age), segment location (CCA, bulb, ICA), and risk factor by 
segment interaction terms.  This was a single model with IMT as the dependent variable and 
multiple lines of data per woman, corresponding to each IMT segment.  As expected, significant 
main effect associations with IMT were found across the three locations for weight (β=0.007 per 
5 kg, p<.001), SBP (β=0.008 per 10 mmHg, p=.008), current smoking (compared to never 
β=0.037, p=.005) and apoprotein B (β=0.006 per 0.1 g/L, p=.01) with a trend for age at scan 
(β=0.02 per 5 years, p=.08).  Results were the same for never and former smokers.  Significant 
interaction effects (signifying segment-specific effects) were found between location and SBP 
(p=0.02), smoking (p=0.01) and apoprotein B (p=0.02).  Specifically, simple effects estimates 
(Table 2-4) revealed a greater effect of weight and age in the CCA than in the ICA; and a greater 
effect for apoprotein B in the ICA than in the CCA.  Smoking and SBP appeared to have an 
effect that was specific to the bulb segment.  In addition, individual estimates showed significant 
segment associations between weight and apoprotein B and bulb location.  There were no main 
or interaction effects for hysterectomy, which was likely a surrogate for age in this sample.  
Thus, significant and unique associations between baseline risk factors and segments exist even 
after accounting for the correlation in IMT at all three locations…  
 
Table 2-2: Intima Media Thickness 
  Control Intervention Pooled Group 
Location n Mean ± SD Mean ± SD Mean ± SD Range 
Common Carotid Artery (mm) 451 0.68 ± 0.08 0.67 ± 0.08 0.67 ± 0.08 0.50 – 1.03 
Carotid Bifurcation (mm) 452 0.74 ± 0.14 0.74 ± 0.16 0.74 ± 0.15 0.46 – 1.78 
Internal Carotid Artery (mm) 447 0.62 ± 0.10 0.62 ± 0.10 0.62 ± 0.10 0.37 – 1.14 
Average (mm) 444 0.68 ± 0.08 0.67 ± 0.08 0.68 ± 0.08 0.51 – 1.00 
 
 
Table 2-3: Multivariable Regression Models of Intima-Media Thickness* 
 Average Common Carotid Artery Carotid Bifurcation Internal Carotid Artery
Risk Factors β C.I. β C.I. β C.I. β C.I. 
Intervention -0.012 -0.026, 0.002 -0.011 -0.025, 0.004 -0.003 -0.031, 0.026 -0.007 -0.026, 0.012 
Peri/Post Menopausal 0.003 -0.018, 0.024 -0.003 -0.026, 0.021 0.007 -0.036, 0.050 0.009 -0.020, 0.038 
Age at Scan (5 yrs) 0.020† -0.002, 0.038 0.024† 0.005, 0.042 0.011 -0.025, 0.047 0.002 -0.022, 0.026 
Weight (5 kg) 0.008§ 0.004, 0.012 0.007§ 0.004, 0.011 0.009† 0.002, 0.017 - - 
SBP (10 mmHg) 0.009‡ 0.003, 0.015 0.008‡ 0.002, 0.014 0.022§ 0.010, 0.033 - - 
Apoprotein B (0.1 g/L) - - - - - - 0.013§ 0.007, 0.019 
Current Smoking 0.029† 0.005, 0.052 - - 0.079‡ 0.031, 0.127 - - 
Hysterectomy - - 0.059† 0.010, 0.108 - - - - 
Adjusted R2 0.10 0.09 0.07 0.03 
* Each of the four models included scan age, intervention group, menopausal status and any characteristic that was significantly 
correlated (p<0.15) with that IMT measure from univariate analyses.  C.I.=95% Confidence Interval. A dash (-) indicates that the 
variable was not included/retained in the model for that segment because it was not significant. 
†p<0.05;  ‡p<0.01;  §p<0.001 
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Table 2-4: Linear Repeated Measures Model of Intima-Media Thickness* 
 Location 
 Common Carotid Artery  Carotid Bifurcation  Internal Carotid Artery 
Risk Factors β C.I.  β C.I.  β C.I. 
Intervention Group -0.012 -0.033, 0.008  -0.007 -0.027, 0.014  -0.006 -0.027, 0.015 
Peri/Post Menopausal -0.002 -0.034, 0.030  0.010 -0.022, 0.043  0.001 -0.031, 0.034 
Age at Scan (5 yrs) 0.027† 0.001, 0.053  0.018 -0.008, 0.044  0.006 -0.020, 0.032 
Weight (5 kg) 0.008‡ 0.003, 0.014  0.009§ 0.004, 0.015  0.004 -0.002, 0.009 
SBP (10 mmHg) 0.006 -0.002, 0.015  0.016§ 0.008, 0.025  0.002 -0.006, 0.011 
Apoprotein B (0.1 g/L) -0.000 -0.007, 0.007  0.007† 0.001, 0.014  0.011§ 0.005, 0.018 
Smoking: Current vs. Never 0.010 -0.025, 0.046  0.077§ 0.041, 0.112  0.024 -0.011, 0.060 
                Current vs. Former -0.001 -0.038, 0.035  0.073§ 0.036, 0.110  0.023 -0.013, 0.060 
Hysterectomy 0.031 -0.032, 0.094  -0.023 -0.086, 0.040  0.001 -0.063, 0.064 
* This was a single model with IMT as the outcome measures and included all of the above covariates, IMT measurement location, 
and location by risk factor interaction effects.  C.I.=95% Confidence Interval. 
†p<0.05;  ‡p<0.01;  §p<0.001 
 
 
2.5 DISCUSSION 
Our research shows that cardiovascular risk factors may differentially influence atherosclerosis 
in carotid arterial segments in healthy middle-aged women.  Further, repeated measures 
regression, which has not been used in previous studies of carotid segments, showed that these 
segment-specific associations were statistically significant when locations were directly 
compared. 
Results of this study build on our previous findings of carotid atherosclerosis, where we 
reported on average IMT in a subset (n=292) of the study sample.7  Similar associations between 
cardiovascular risk factors and average IMT were found.  Additionally, segment-specific 
analyses were possible with the larger sample size.   
2.5.1 Segment-Specific Carotid IMT 
Unique to our study were the examination of IMT by carotid segment in healthy, primarily 
premenopausal women and the examination of risk factor and location interactions.  Variations 
in methodology, including use of older women or heart clinic patients, make others’ results of 
IMT by carotid segment challenging to compare.8-13  Nonetheless, similarities between our 
results and those previously published include positive associations of SBP and body 
composition with CCA and bulb IMT,10;11;13 lipids associated with bulb and ICA IMT,9;11;13 and 
smoking with bulb IMT.11  In contrast, neither lipids nor smoking were found to be associated 
with CCA IMT in our analyses.9;11;13  Nor did we find older age associated with higher IMT 
across segments,10 although this may be due to our narrow age range.  Further, others have 
generally found the segments similarly associated with cardiovascular risk factors,10;11;13 whereas 
we found distinct differences in risk factor and segment associations.  Examining more diseased 
populations may have made it harder for others to tease out unique associations.   
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2.5.2 Theories on Differential IMT 
Various mechanical and biochemical pathways and the risk factors themselves are most certainly 
acting in conjunction and possibly synergistically to determine the development and progression 
of atherosclerosis at any given site.23;24  The moderate level of IMT we found in the CCA 
(compared to the ICA and bulb) is likely due to the lower sheer wall force18;19;32 that is consistent 
with the laminar blood flow33 in this location.  Its association with higher weight is consistent 
with the positive relationship commonly found between body size and atherosclerosis and CCA 
IMT.34   Diabetes, which is associated with obesity, is thought to decrease wall shear stress and is 
positively associated with CCA IMT.35  Finally, aging, which itself is associated with increased 
CCA IMT,3;11;13;32 is also inversely related to shear stress.32 
Our positive association between apoprotein B and ICA IMT is consistent with research 
on sheer stress and lipids regarding influences on IMT.  In the ICA segment, the smaller wall 
thickness, relative to the other segments, is likely attributable to the mix of laminar and 
oscillatory shear stress around the arterial wall.19  Infiltration of lipids during extended contact of 
blood with the wall has been linked to areas of low shear stress,36 which portions of this segment 
experience.  Additionally, shear stress influences cellular processes such as increase in growth-
regulatory factors,16;22 expression of inflammatory molecules24 and response of pro-oxidant 
processes,33 which have also been linked to LDL and atherosclerosis,37;38 although not 
specifically to the ICA segment.  
Not surprisingly, the bulb, which connects the CCA and ICA segments, was associated 
with risk factors linked to each site.  The bulb experiences the most oscillatory stress and 
turbulence as a result of reverse flow velocity components occurring during pulsatile flow19;32;33 
and consequentially exhibited greater wall thickness and was associated with higher SBP in our 
sample.  The higher bulb IMT may also be a function of plaque, which is commonly found in 
this location,39 and was evident in the bulb in 18.3% of our sample (post hoc; plaque defined as a 
distinct area protruding into the vessel lumen with > 50% thickness than surrounding area).  The 
influence of shear stress on the extracellular factors of hypertension such as increased pressure,16 
decreases in vasoactive agents17 and inflammatory effects,14 would have the largest impact on the 
bulb segment.  Research on increased residence time of blood36 and adherence of platelets and 
macrophages to the arterial wall,40 which influence lipid infiltration and plaque formation, is 
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consistent with our positive association between apoprotein B and bulb IMT.  The increased 
residence time might also make the bulb more susceptible to the toxic components of cigarette 
smoke.15   
Several study limitations should be mentioned.  First, the wide time range between 
baseline and scan visits may have influenced results, although 91% of participants had scans 
within one standard deviation of the mean interval.  Post hoc, we substituted ‘time interval’ and 
‘age at baseline’ for the covariate ‘age at scan’ in regression models.  Longer time interval 
replaced older age at scan as a significant predictor of higher average and CCA IMT, thus the 
model adequately adjusted for time.  Second, risk factors explained only 3-9% of IMT segment 
variance, so other atherosclerotic mechanisms and pathways should continue to be examined.  
However, given the healthy status, young age, and low levels of IMT in our sample, the link 
between specific IMT segments and risk factors are noteworthy; and comparable to the 12-22% 
segment variance found by Wei and colleagues,13 whose sample included diabetic subjects.  
Further, the enrollment exclusion criteria (i.e. requiring normal to high-normal ranges for DBP, 
BMI, glucose and lipids) likely reduced the effects of these risk factors and potentially increased 
the relative contribution of other risk factors (e.g. hysterectomy).  Third, there may have been 
some influence of the intervention that was not detected in our analyses, since the clinical trial 
was successful in minimizing increased weight and LDL that traditionally occur with 
menopause.25-27  Lastly, we examined a healthy, homogeneous sample of women, who may not 
be representative of the general population and thus may have underestimated associations.  
Future research should include other groups for a better understanding of segment-specific 
associations and their influences on clinical events. 
In conclusion, cardiovascular risk factors traditionally associated with overall mean 
carotid IMT may differentially influence wall thickening of the carotid artery segments in 
middle-aged, healthy women, even after adjusting for other cardiovascular risk factors and wall 
thickness in all three segments. 
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3.1 ABSTRACT 
Objectives:  To examine associations between rheumatoid arthritis (RA) diagnosis and 
characteristics and evidence of carotid atherosclerosis.  We take a unique approach by evaluating 
lumen and interadventitial diameters, in addition to intima-media thickness (IMT) and plaque.   
Methods:  Ninety-three women with RA were matched with 93 healthy women by age, 
race and menopausal status.  In cross-sectional analyses, common carotid artery measures were 
compared between groups and in association with measures of RA severity and activity.   
Results:  Mean age was 53.3 years.  Median RA duration was 14 years.  Lumen diameter 
(5.50 vs. 5.19 mm) and interadventitial diameter (6.92 vs. 6.61 mm) were significantly wider in 
patients than healthy women, respectively (P < 0.001 for both).  Diagnosis of RA was 
independently associated with larger lumen (β = 0.256, P < 0.01) and interadventitial (β = 0.261, 
P < 0.01) diameters, after controlling for cardiovascular risk factors and IMT.  Carotid IMT 
(0.70 vs. 0.71 mm) was similar, and prevalence of plaque in patients (21%) was higher but not 
statistically different than healthy women (15%).  In patients with RA, we found positive 
associations between methotrexate dose and interadventitial diameter, between hypothyroidism 
and IMT, and between hypothyroidism and soluble endothelial adhesion molecule and plaque, 
independent of cardiovascular risk factors. 
Conclusions:  Women with RA have increased carotid artery diameters compared to 
healthy women.  This may reflect premature vascular aging and be an early indicator of 
increased cardiovascular risk. 
Key Words: rheumatoid arthritis, atherosclerosis, carotid arteries 
3.2 INTRODUCTION 
Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disorder that affects 1% of the 
U.S. population, particularly women of childbearing and early menopausal ages.151,152  In 
patients with RA, cardiovascular disease is a major determinant of morbidity and is the leading 
cause of death.157,159,243  To detect the burden of cardiovascular disease in RA, use of 
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noninvasive measures such as carotid ultrasound has been promoted to identify subjects with 
preclinical atherosclerosis.84-96  Serum markers of inflammation are similarly being explored, 
given their link with cardiovascular disease in the general population and in patients with 
RA.86,89,91,161,163,164,166-168,197,244  Ultimately, these measures might identify patients most 
appropriate for aggressive cardiovascular risk factor reduction and be used to monitor efficacy of 
interventions to reduce risk.  
Carotid ultrasound measures of lumen diameter, interadventitial diameter, intima-media 
thickness (IMT) and plaque have been evaluated as early indicators of systemic atherosclerosis 
in non-RA populations and are informative measures of vascular health.73-76  Changes in these 
four carotid structures are interdependent,241,242 occurring as both part of the natural aging 
process and in response to insult or injury.  Arterial dilatation (i.e. vascular remodeling) is 
considered to begin as an adaptive response to changes in wall shear stress concomitant with 
increased wall thickness,63,74,75,108-110 but ultimately, larger carotid diameter is a marker of 
vascular aging and is associated with cardiovascular risk factors and increased risk of myocardial 
infarction.61,63,75,111,112  IMT is increased in individuals with coronary heart disease and 
myocardial infarction, is associated with numerous cardiovascular risk factors, and predicts 
future risk of cardiovascular events.1,2,4  Carotid plaque has been linked with specific 
cardiovascular risk factors and ischemic stroke.60,107   
Thus far, carotid ultrasound findings in RA subjects have generally not reported outcome 
measures of lumen or interadventitial diameter.  While studies typically find common carotid 
IMT to be higher in patients with RA compared to controls,84-89,95 several studies have found no 
difference90-92 or the opposite results.94  Looking at carotid diameter in conjunction with IMT 
and plaque may provide new insight into these discrepancies.  Further investigation of indicators 
of RA severity and activity with atherosclerosis, particular diameters measures, is also 
warranted.   
The purpose of our study was twofold.  We sought to i) compare carotid arterial 
diameters, IMT and plaque in women with RA to matched healthy women; and ii) evaluate the 
associations between RA-related factors and indicators of early carotid disease in patients with 
RA.   
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3.3 MATERIALS AND METHODS 
3.3.1 Participants 
Women with RA volunteered for a study of cardiovascular disease prevalence and risk factor 
assessment from a University-based outpatient rheumatology practice and the University of 
Pittsburgh Medical Center (UPMC) Arthritis Network Disease Registry.  (Registry participants, 
who gave signed consent to be notified in writing of research opportunities, were comprised of 
RA patients from the University and two University-affiliated, community-based practices.)  
Eligible women (n=104) were greater than 30 years old and met American College of 
Rheumatology criteria for RA 245 for at least two years. 
Healthy participants were selected from 535 women who participated in the Women’s 
Healthy Lifestyle Project, an intervention trial examining cardiovascular risk factors during 
menopause.25,27  At enrollment, these women were aged 44-50 years with no indication of 
cardiovascular disease.  As part of an ancillary study, 85% of participants had carotid ultrasound 
scans an average of five years after enrollment, during which some changes in health status 
developed (e.g. hypertension, diabetes).  Healthy participants eligible for the current analysis 
completed a scan (n=453) and were randomized to the assessment-only (i.e. non-intervention) 
arm of the study (n=275).   
Patients with RA and healthy participants were matched by age (± 5 years), menopausal 
status and race.  Arterial diameter measures were not available on all subjects because this 
protocol component was not initially included and was unobtainable post-hoc.  The final sample 
consisted of 93 patients with RA and 93 healthy women with IMT and plaque measures, and 78 
patients and 90 healthy women with diameter measures.   
The RA cardiovascular study, intervention trial, and carotid scan protocols were 
approved annually by the Institutional Review Board of the University of Pittsburgh.  All 
participants provided informed written consent.   
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3.3.2 Clinical Measures 
Clinical data and traditional cardiovascular risk factors81 were obtained through patient interview 
and physical examination (Table 3-1).  Fasting blood samples were assayed at the Department of 
Epidemiology Nutrition Laboratory.  Resting systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) were averaged from two seated measurements; height and weight were used to 
calculate body mass index (BMI; kg/m2).  Women were assessed for hormone therapy use (any 
in the prior year), hypertension (SBP ≥ 140 mmHg, DBP ≥ 90 mmHg 246 and/or antihypertensive 
drugs), diabetes (glucose ≥ 6.99 mmol/L (126 mg/dL) 247 and/or medication) and 
hypercholesterolemia (cholesterol ≥ 5.17 mmol/L (200 mg/dL) 248 and/or lipid-lowering drugs).  
Menopause status was based on participant self-report, plus endogenous hormone levels in 
patients with RA.  For analysis, menopause status was dichotomized as postmenopausal (no 
bleeding cycle or taking hormone therapy for ≥ 12 consecutive cycles, or hysterectomy) versus 
not (i.e. pre- or perimenopausal).  Measures were collected within approximately one month and 
one year of the ultrasound scan for patients with RA and healthy participants, respectively, 
because protocols regarding timing of visits varied for the two studies. 
3.3.3 Rheumatoid Arthritis Features and Inflammatory Markers 
Patients with RA were also evaluated for the characteristics listed in Table 3-2.  Soluble 
endothelial adhesion molecule (sE-selectin) was measured using a high sensitivity quantitative 
sandwich enzyme assay and determined colorimetrically; soluble intercellular adhesion molecule 
(sICAM-1) was measured by an ELISA assay and determined by colorimetric reaction (assays 
from R&D Systems, Minneapolis, MN; completed at the Laboratory for Clinical Biochemistry 
Research, University of Vermont, Burlington, VT).  Additional laboratory variables were 
measured by routine methods 
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3.3.4 Carotid Ultrasound Measures 
Arteries were examined using an ultrasound scanner (Toshiba SSA-270A, Tustin, CA) equipped 
with a 5-MHz linear array imaging probe.  With participant in the supine position, left and right 
arteries were viewed at end diastole in transverse and longitudinal projections.   
Common carotid near and far walls were examined 2 cm proximal to the bifurcation.  
Digitized images were used to trace the media-adventitial and intima-lumen interfaces across 1-
cm lengths and IMT was computed as the average of both arteries.  Lumen diameter was 
measured as the distance between the lumen-intima interfaces of the left common carotid artery, 
where the walls were parallel and there was no evidence of plaque.  Interadventitial diameter was 
calculated as the distance between the adventitia-media interfaces.   
Carotid arteries were evaluated for the presence of eccentric focal plaque in the 
bifurcation, internal and common areas.  Plaque was defined as a distinct area protruding into the 
vessel lumen with ≥ 50% thickness than the surrounding area.  Degree of plaque was categorized 
as no/small plaque (< 30% of vessel diameter), and medium/large/multiple plaques (≥ 30% 
stenosis).  This categorization captured the severity distinction of our sample more appropriately 
than either dichotomizing as plaque “any versus none” or totaling the number of plaques. 
Scans were completed by trained technicians in the same lab and read later by technicians 
blinded to study group.  The lab has shown IMT, plaque and diameters to be reliable measures of 
carotid atherosclerosis.  For each measure, the reproducibility coefficient was ≥ 0.82 and the 
intraclass correlation coefficient was ≥ 0.84.30,249 
3.3.5 Statistical Analysis 
In this cross-sectional study, patients with RA and healthy women were compared using 
unpaired tests.  Univariate associations between clinical measures and carotid outcomes were 
examined via Pearson/Spearman correlation, t-tests and chi-square tests, as appropriate.  Because 
of their skewed distribution inflammatory markers were both log transformed and divided into 
quartiles. 
In multivariable analyses, dependent (outcome) measures were IMT, lumen diameter, 
interadventitial diameter (all linear regression), and plaque (logistic) with RA diagnosis as the 
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independent variable.  Models were adjusted for cardiovascular risk factors determined via 
univariate associations.  In diameter models, height was included to account for body size.  To 
control for potential confounding between the two groups, diameter models controlled for IMT, 
while the IMT model was adjusted for interadventitial diameter.  For RA-only regression, each 
RA characteristic was individually added to the above determined multivariable cardiovascular 
risk factor model for each outcome.   
All analyses were implemented using the SAS system for windows version 8.2 (SAS 
Institute, Cary, NC).  Values of p ≤ 0.05 were considered significant. 
3.4 RESULTS 
The combined group was 97% Caucasian, 68% postmenopausal and 53.3 ± 3.9 years old.  
Patients with RA had higher BMI, blood pressure and triglycerides, and were more likely to be 
never smokers and have been diagnosed with hypertension (Table 3-1).  Healthy women had 
higher fasting glucose levels than patients with RA.  Patients with RA had larger lumen and 
interadventitial diameters than healthy participants.  There was no difference in IMT between 
subjects.  The higher plaque prevalence in patients with RA was not statistical different from 
healthy women. 
For patients, average age at RA diagnosis was 37 years, with a median disease duration 
of 14 years, and 71% reported experiencing morning stiffness, lasting one hour on average 
(Table 3-2).  Patients with RA who had diameter measures were generally similar to patients 
who did not have diameter measures (data not shown). 
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Table 3-1: Comparison of Healthy Women and Patients with Rheumatoid Arthritis 
(RA)* 
Characteristic  Healthy Women (n=93) 
Patients with RA 
(n=93) P-value 
Clinical Measures:    
Mean age, range (years) 53.2, 46.7 – 58.7 52.9, 42.0 – 60.2 0.62 
Current/Former/Never smokers (%) 7 / 51 / 35 12 / 31 / 50 0.01 
Diabetes 2 (2%) 3 (3%) 0.65 
Glucose (mmol/L) 5.61 ± 0.57 4.98 ± 1.07 <0.001 
Body mass index (kg/m2) 25.8 ± 3.4 28.4 ± 6.5 0.001 
Hypertension  11 (12%) 27 (29%) 0.004 
Systolic blood pressure (mmHg) 110.5 ± 12.7 120.5 ± 17.9 <0.001 
Diastolic blood pressure (mmHg) 70.8 ± 7.9 77.3 ± 10.4 <0.001 
Hypercholesterolemia 51 (55%) 59 (63%) 0.23 
Total cholesterol (mmol/L) 5.38 ± 0.78 5.30 ± 0.83 0.26 
High density lipoproteins (mmol/L) 1.61 ± 0.36 1.52 ± 13.3 0.12 
Low density lipoproteins (mmol/L) 3.22 ± 0.69 3.11 ± 0.78 0.34 
Triglycerides (mmol/L) 0.94 [0.77, 1.39] 1.32 [0.98, 1.70] <0.001 
Current hormone therapy  36 (44%) 35 (38%) 0.36 
    
Carotid ultrasound measures:    
Lumen diameter (mm)  5.19 ± 0.47 5.50 ± 0.60 <0.001 
Interadventitial diameter (mm)  6.61 ± 0.54 6.92 ± 0.67 <0.001 
Intima-media thickness (mm) 0.71 ± 0.08 0.70 ± 0.10 0.94 
Presence of plaque  14 (15%) 19 (21%) 0.29 
 
* Characteristics are summarized as mean ± standard deviation or median [inter-quartile range] 
unless otherwise indicated. 
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Table 3-2: Additional Characteristics for Women with Rheumatoid Arthritis* 
Characteristic   
Age at rheumatoid arthritis diagnosis (years ) 37.3 ± 10.9 
Disease duration since diagnosis (years) 14 [7, 23] 
Rheumatoid factor positive  64 (73%) 
Morning stiffness 65 (71%) 
Extra-articular disease  73 (78%) 
Health Assessment Questionnaire Disability Index 208 0.75 ± 0.57 
Number of prior disease modifying antirheumatic drugs [DMARDs] (ever) 3.5 + 1.9 
Current nonsteroidal anti-inflammatory drug use 69 (75%) 
Current prednisone use 38 (41%) 
       Daily prednisone dose (mg) 5.4 ± 3.5 
Current methotrexate use 57 (61%) 
       Weekly methotrexate dose (mg) 14.5 ± 5.1 
Current tumor necrosis factor inhibitor use 35 (38%) 
Hypothyroidism 12 (13%) 
Erythrocyte sedimentation rate [ESR] (mm/h) 10.0 [5.0, 24.5] 
High sensitivity C-reactive protein [hsCRP] (mg/L) 5.6 [2.2, 13.0] 
Fibrinogen (μmol/L) 9.3 [7.6, 10.8] 
Plasminogen activator inhibitor type 1 [PAI-1] (μg/L) 19.3 [10.4, 45.0] 
Soluble intercellular adhesion molecule [sICAM-1] (ng/ml) 271 [232, 335] 
Soluble endothelial adhesion molecule [sE-selectin] (ng/ml) 40.3 [29.7, 64.5] 
* Characteristics are summarized as mean ± standard deviation or median [inter-quartile range] 
unless otherwise indicated. 
 
3.4.1 Regression Models – Rheumatoid Arthritis vs. Healthy Women 
Based on univariate analyses, the following covariates were included in multivariable models: 
hypertension (positively associated with all carotid outcomes), hypercholesterolemia (positively 
associated with plaque) and glucose (positively associated with IMT).  [Hypertension and 
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hypercholesterolemia were chosen over individual blood pressure and lipid measures that 
showed positive univariate associations but would not capture women under treatment.  
However, this principle was not possible for glucose because of the extremely small number of 
women meeting criteria for diabetes.]  Age and race (both positively associated with IMT) were 
included as demographic characteristics in the models.   
 
Table 3-3: Multivariable Regression Models of Carotid Artery Outcomes* 
 Dependent Outcomes 
 Lumen 
Diameter 
(mm) 
Interadventitial 
Diameter 
(mm) 
Intima- 
Media 
Thickness 
(mm) 
Plaque 
Risk Factor  β β β OR 
Rheumatoid arthritis diagnosis 0.270‡ 0.275‡ -0.015 1.66 
Age (year) 0.012 0.010 0.002 1.12† 
African American race -0.199 -0.168 0.088† 2.61 
Hypertension 0.274‡ 0.290‡ -0.013 1.23 
Hypercholesterolemia  -0.013 0.003 0.005 2.46† 
Glucose (mmol/L) -0.022 -0.027 0.014† 1.37 
Height (cm) 0.017‡ 0.017‡ – – 
Intima-media thickness (mm) 1.021† 3.084§ – – 
Interadventitial diameter (mm) – – 0.071§ – 
* The first six risk factors were included in the model for each dependent outcome; additionally, 
height and intima-media thickness were included in the diameter models, while interadventitial 
diameter was included in the intima-media thickness model.  β=regression coefficient, 
OR=odds ratio. 
† p<0.05;  ‡ p<0.01;  § p<0.001 
 
 
 
In regression analyses adjusted for these cardiovascular risk factors and IMT, RA diagnosis was 
positively associated with wider lumen and interadventitial diameters (Table 3-3).  Thus, on 
average, diameters for patients with RA were 0.27 mm wider than controls.  These results did not 
change if IMT was omitted from the models.  In contrast, IMT was similar between groups, 
whether or not diameter was in the model.  Similarly, RA diagnosis was not associated with the 
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presence of plaque in multivariable models.  Results were essentially the same when other 
cardiovascular risk factors were considered as covariates, such as substituting SBP for 
hypertension or adding smoking to the models.  Hypertension was the only cardiovascular risk 
factor associated with diameters, while African-American race (plus age when interadventitial 
diameter was omitted) was associated with IMT.  Age and hypercholesterolemia were positively 
associated with presence of plaque 
3.4.2 Rheumatoid Arthritis Factors and Carotid Outcomes 
Unadjusted analyses in patients with RA showed average daily dose of prednisone was positively 
associated with lumen and interadventitial diameters (Spearman’s r = 0.46, P = 0.008; and r = 
0.47, P = 0.006, respectively).  RA duration was positively associated with IMT (Spearman’s r = 
0.21, P = 0.04), but this relationship disappeared after controlling for age.  Average weekly dose 
of methotrexate was positively associated with interadventitial diameter and IMT (Spearman’s r 
= 0.33, P = 0.02; and r = 0.33, P = 0.01, respectively).  The highest quartile of values for hsCRP, 
sE-selectin and PAI-1 were associated with a small but non-significant increase in diameter and 
plaque measures.  There was a significant negative association between continuous sICAM-1 
and IMT (Spearman’s r = -0.23, P = 0.03).      
In multivariable models in women with RA, no indicator of RA activity was associated 
with lumen diameter when individually added to the model controlling for cardiovascular risk 
factors.  For RA women currently taking methotrexate, weekly dose was positively associated 
with interadventitial diameter (Table 3-4); however, this association was no longer significant 
when age was replaced with duration of disease and age at diagnosis, or when IMT was added to 
the multivariable model.  Current prednisone use was associated with decreased IMT, while 
hypothyroidism was associated with increased IMT in separate models.  These associations 
remained the same when interadventitial diameter was included, or if duration of disease and age 
at diagnosis were substituted for age.  Plaque was positively associated with sE-selectin and 
hypothyroidism in individual models controlling for traditional cardiovascular risk factors.  No 
other RA feature was significantly associated with carotid outcomes in multivariable models; 
however, other inflammatory markers and medications showed significant trends (P < 0.15). 
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Table 3-4: Multivariable Regression Models of Significant Rheumatoid Arthritis 
Factors Associated with Carotid Outcomes in Patients* 
 Dependent Outcomes 
 Interadventitial
Diameter 
(mm) 
Intima-Media  
Thickness 
(mm) 
 
Plaque 
Risk Factor  β β β  OR OR 
Age (year) 0.022 0.004 0.003  1.29 1.16 
African American race 0.818 0.101 0.121†  3.65 – 
Hypertension 0.166 0.013 0.008  0.98 1.43 
Hypercholesterolemia  0.120 0.018 0.026  2.23 2.68 
Glucose (mmol/L) 0.023 0.010 0.011  1.19 1.23 
Height (cm) 0.019 – –  – – 
Weekly methotrexate dose (mg) 0.040† – –  – – 
Prednisone user – -0.057‡ –  – – 
Hypothyroidism – – 0.085‡  7.25† – 
Log of sE-selectin (ng/ml) – – –  – 3.09† 
* The first five risk factors were included in each individual model, plus height for diameter; the 
remaining factors were individually added in respective models for each outcome 
(interadventitial diameter, intima media thickness and plaque).  All significant associations are 
displayed, resulting in varying number of columns per outcome.  β=regression coefficient, 
OR=odds ratio, sE-selectin=soluble endothelial adhesion molecule.  Race was dropped from 
one plaque model because of missing data. 
† p<0.05;  ‡ p<0.01 
 
3.5 DISCUSSION 
This study is the first to describe wider carotid artery lumen and interadventitial diameters in 
women with RA compared with matched healthy women, independent of traditional 
cardiovascular risk factors and IMT.  In the women with RA, positive associations were found 
between methotrexate dose and interadventitial diameter, between hypothyroidism and IMT, and 
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between sE-selectin and hypothyroidism and plaque, each independent of cardiovascular risk 
factors.  These findings may indicate evidence of accelerated vascular aging and early 
atherosclerotic risk among women with RA 
3.5.1 Vascular Adaptation or Rheumatoid Arthritis-Specific Effrect 
Vascular remodeling is a dynamic, early response to risk factors, wall thickening and increased 
wall shear stress.63,74,75,108-110  Concomitant increase of carotid diameters allows lumen cross-
sectional area and arterial flow to be kept constant and maintains or decreases IMT by 
distributing it over a larger area.  Since the artery has a limited capacity to dilate, continued 
increase in IMT and plaque will ultimately result in reduction of blood flow.73,74,110,199  Arteries 
unexposed to risk factors and free of atherosclerosis maintain a normal size with aging in the 
general population.75  Thus, enlarged diameters can be considered a sign of vascular adaptation 
and a marker for early atherosclerosis. 
Alternatively, our results may reflect a unique, RA-related atherogenic effect on arterial 
diameters (rather than traditional vascular adaptation) that is specific to RA itself rather than a 
result of remodeling in response to thickened IMT.  Perhaps the underlying autoimmune disease 
process, its treatment, or an interplay between the two accounts for a change in the evolution of 
atherosclerotic vascular disease in these patients.  In contrast, diameter differences were not 
found among treatment groups or compared to controls in separate studies.92,250  While we found 
links between RA-related factors and carotid outcomes, our study does not elucidate the pathway 
by which these changes occurred.  However, published evidence to date suggests chronic 
systemic inflammation may lead to endothelial dysfunction and accelerated atherogenesis in 
patients with RA.166-168,244 
3.5.2 Comparisons with Existing Literature 
Our finding of similar common carotid IMT between groups is consistent with several studies of 
RA patients in the United States, where the average age was less than 50 or greater than 60 years 
old.  A large study of RA men and women found no difference in carotid IMT compared with 
controls.91  Another reported no difference in IMT between women with RA, women with 
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systemic lupus erythematosus, and controls, and found that patients with lupus had larger carotid 
artery diameters than controls.92  In a small Italian study, internal carotid IMT was higher in 
patients with RA, while common carotid IMT was similar to controls.90  Finally, Roman and 
colleagues found IMT in patients with RA to be less than controls.94  Perhaps arterial dilatation 
in RA patients in these studies is maintaining a stable IMT.   
Differences in study populations may explain some of the discrepancies between our IMT 
results and previous investigators, who found higher common carotid wall thickness in patients 
with RA compared to controls.84-89,95  In contrast to the subjects we describe, these studies 
generally report on slightly older patients with a wider age spectrum (average age 55, range 36-
85 years), and enrolled both men and women.  Research indicates that IMT increases with 
age,75,198 with menopausal status independent of age,146 and is greater in men.4  Thus, our sample 
of slightly younger women with a narrower age range may have been studied at an earlier point 
on an arterial remodeling continuum than those described elsewhere, with our RA women having 
vessel wall dilatation and thus preserved IMT.  A study of IMT progression 93 in women with 
RA found an accelerated rate of annual wall thickening when compared to healthy controls.  If 
followed over time, a divergence in IMT may be seen between our subject groups as well.  
Given our results, it can not be said with certainty whether all women with RA have 
greater IMT than healthy controls, or if this difference is only observed in women of certain ages 
or ethnicities, at particular time points in the course of disease (RA or atherosclerosis), or in 
conjunction with health and population of controls.  Based on patient ages, results suggest a 
curvilinear relationship, where IMT is similar between patients and controls at younger and older 
ages.  Interestingly, carotid IMT in our healthy women (mean 0.71 mm) was much higher when 
compared to several previous studies (common carotid IMT 0.58-0.68 mm), while IMT in our 
patients with RA was similar (range 0.64-0.77 mm).84-86  Thus, while there is evidence that IMT 
may differ between patients with RA and controls, the course of progression may be distinct 
from other conditions where increased IMT is seen at a very early stage of atherogenesis.   
In regards to carotid plaque, several studies reported no difference in plaque 
prevalence,84-86,89,91 while others have found increased carotid plaque in patients with 
RA.88,90,92,94,95  Sample size may have limited our ability to detect between groups a statistically 
significant difference in plaque, which was clinically higher in our women with RA.  Plaque 
frequently occurs in areas of transition or turbulence (e.g. internal carotid artery or 
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bifurcation),110 therefore variations in methodology (i.e. area of plaque assessment) may be 
influencing results.   
3.5.3 Rheumatoid Arthritis Factors 
We found several RA-related risk factors associated with measures of carotid atherosclerosis.  
Others also have reported a positive association between duration of disease and 
IMT.85,86,95,171,196,197  As was found here, RA medications may be positively 94,169 or negatively 
161 associated with atherosclerosis.  Incongruencies are possible because pharmacological 
treatment can be interpreted as a marker for RA severity, contributing adversely to 
cardiovascular risk factors (e.g. hypertension) or conversely, exerting a protective effect by 
reducing RA-related systemic inflammation.163,203-205  Type, effectiveness and side effects of 
medications influence when and how they are prescribed, which may also affect their 
associations with atherosclerosis.  Additionally, studies vary on whether current, cumulative, or 
multiple medication exposure is considered.  Previous studies have linked hypothyroidism with 
IMT and plaque in patients with RA171,196 and with accelerated atherosclerosis in non-RA 
patients.251  Impaired lipid metabolism/profiles, obesity, high homocysteine levels and effects of 
thyroid hormones on vascular cells are all potential pathways for this link.  
While the relationship between inflammatory markers and atherosclerosis in patients with 
RA has been inconsistent across studies, logical pathways by which systemic inflammation 
contributes to atherogenesis in patients with RA have been reviewed.166-168  The cross-sectional 
nature of our study and others does not capture the changing inflammatory milieu over time in 
patients with RA.  Further, the clinical course of RA is exceedingly variable, ranging from mild, 
self-limiting arthritis to rapidly progressing multi-system inflammation.152  Like others,85,94 we 
did not find a relationship between either CRP or ESR and atherosclerosis, although a positive 
association between these and IMT and/or plaque has been noted elsewhere.91,93,166,197  Others 
have reported a positive association between sICAM-1 and IMT and between sE-selectin and 
plaque.161  Similarly, we found a positive association between sE-selectin and plaque.  
Inflammation in RA has been most consistently linked to endothelial function, another early 
marker of atherosclerosis.166  
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3.6 CONCLUSIONS 
While the strength of our study was the use of ultrasound measures novel for patients with RA, 
namely arterial lumen and interadventitial diameters, it was unfortunate that 18 subjects were 
missing these measures.  Nonetheless, by examining carotid diameter we were able to 
demonstrate early signs of vascular aging and atherosclerotic risk in women with RA. 
In conclusion, our study of patients with RA is unique and noteworthy.  We used a 
carotid ultrasound technique not typically reported for detecting vascular aging in an RA sample.   
We found greater carotid arterial diameters in women with RA compared with matched healthy 
women, whereas IMT was similar.  We propose that lumen and interadventitial diameters may be 
more sensitive measures of early atherosclerosis in women with RA than ultrasound 
measurement of IMT and plaque, and may explain previous discrepancies.  Carotid diameter 
vascular remodeling may be an important step in atherogenesis in this autoimmune disease and 
should be included in measures of early atherosclerotic cardiovascular disease in patients with 
RA.   
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4.1 ABSTRACT 
Background:  A limited number of studies have examined associations between negative affect 
and endothelial dysfunction via brachial artery flow-mediated dilation (FMD). 
Purpose:  To examine which psychosocial measures are associated with FMD. 
Methods:  FMD was examined in 332 healthy older adults.  Measures included Beck 
Anxiety and Depression Inventories, Cook-Medley Hostility Scale and Spielberger State-Trait 
Anger Expression Inventory (Anger In, Anger Out and Trait Anger).  
Results:  Mean age was 60.5 ± 4.8 years, 76% of participants were Caucasian and 50% 
were female.  FMD was greater in women compared to men (6.17 vs. 4.07, P < 0.001).  Women 
reported significantly greater Anxiety (p < .001) and men reported greater Hostility (p=0.004).  
In separate multivariable linear regression models controlling for cardiovascular risk factors, plus 
current hormone therapy for women, smaller FMD was associated with higher Anger In for 
women (β=-0.223, p=0.04) and with higher Hostility (β=-0.108, p=0.02) and Trait Anger (β=-
2.360, p=0.12) for men.   
Conclusion:  Endothelial dysfunction, as indicated by less vasodilatation of the brachial 
artery, is positively associated with cognitive-type measures of negative affect in healthy older 
adults.  Thus, associations between negative affect and cardiovascular health may be apparent 
very early in the disease process. 
Key Words:  flow-mediated dilation, endothelial dysfunction, anger, hostility, depression 
4.2 INTRODUCTION 
It has long been postulated that negative emotions play a role in the etiology of physical illness; 
and multiple physiological and behavioral pathways have been identified.  In particular, there is 
strong evidence linking negative affect and cardiovascular disease (reviewed by183-187,252), 
whether clinical events 55,57,175,209-215 or subclinical outcomes 214-220 are examined.  Further, 
certain psychological traits (e.g. anger and hostility,172 and possibly depression173) can be 
considered chronic or dispositional (rather than acute or episodic); therefore their influence could 
be comparable to the enduring effects of some traditional cardiovascular risk factors such as 
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hypertension or obesity.  Collectively, these emotions have been referred to as negative 
affectivity, with feelings of hostility, anger suppression and trait anger being categorized as 
cognitive-type, while aggression, anger expression and anxiety are more behavioral in 
nature.173,174 
Identifying at risk individuals early in the disease progression allows for timely 
intervention. Associations between negative affect and cardiovascular disease are found more 
consistently in healthy populations.173  Brachial artery flow-mediated dilation (FMD) is an easy 
to assess, non-invasive technique for evaluating endothelial dysfunction,78,122,123 which is one of 
the earliest signs of insult in the cardiovascular disease continuum.  It is associated with multiple 
cardiovascular risk factors and outcomes and has been suggested as a biomarker of disease, 
similar to IMT and coronary calcification (reviewed by 64,120,121).  Evidence of endothelial 
dysfunction has been found prior to the development of measurable atherosclerosis.138  FMD is 
related to traditional cardiovascular risk factors,78,113-117 provides a surrogate marker for health of 
the coronary arteries,130,132,133 and is an independent predictor of cardiac risk and events in 
clinical populations.65,134,135   
While numerous studies have examined associations between negative affect and 
subclinical cardiovascular disease,214-220 only a limited number have examined the association 
with early endothelial dysfunction via FMD.128,221-225  Three small studies (n < 39) found 
impaired vasodilatation associated with concurrent clinical depression or a history of major 
depression;221-223 and one other found this association in coronary heart disease patients with 
high depressive symptoms.225  Another, looking at the effects of mental stress, found an inverse 
association between hostility and FMD in healthy adults.224  A larger study of postmenopausal 
women that considered multiple measures of negative affect via two psychosocial clusters, 
Anxiety/Depression and Type A/Anger, reported an inverse association between FMD and these 
two factors.128  In the aggregate, these studies have been limited by small sample sizes, the 
inclusion of only a single gender in the one larger study, and/or use of a single predictor, 
primarily evaluating depression.   
Further investigation regarding associations between FMD and several types of negative 
affect in both men and women is warranted.  Studying generally healthy individuals, who have 
not shown clinical signs of cardiovascular disease, implies that the connection is unlikely to be 
biased by knowledge of poor health.  We chose measures previously associated with subclinical 
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cardiovascular disease, specifically, depression, anxiety, hostility and anger.  Our study 
examined whether a link exists between negative emotions and FMD in healthy older adults 
while controlling for traditional cardiovascular risk factors.  
4.3 METHODS 
4.3.1 Participants 
Participants were drawn from the 464 men and women who enrolled from 1998-2000 in the 
Pittsburgh Healthy Heart Project, an observational study examining the bio-behavioral 
determinants of subclinical cardiovascular disease in healthy adults.  The overall study protocol 
included ambulatory blood pressure monitoring, cardiovascular reactivity, interviewer- and self-
administered questionnaires, anthropometric measurements, blood and urine sampling, and 
ultrasound measures, including brachial artery FMD.  These assessments occurred over several 
visits during approximately a 5-month period with several of the measures repeated during a 
three year follow-up phase.  Additional details of the study have been published.228,253,254 
Eligibility criteria included community dwelling and 50-70 years of age.  Additionally, 
women had to be postmenopausal, defined as cessation of menses, use of hormone therapy or a 
hysterectomy at least six months prior to enrollment.  Exclusion criteria included current use of 
anti-hypertensive or lipid-lowering medications, history of heart disease or stroke, diabetes 
requiring insulin, other severe chronic disease (e.g. renal, liver, neurological), cancer treatment in 
past 6 months, or excessive alcohol consumption (5 or greater portions 3 or more times per 
week).  Individuals were also excluded if they were unable to wear a portable blood pressure cuff 
for several days (e.g. body size, occupation) or had high blood pressure (systolic > 180 mmHg or 
diastolic > 110mmHg).  Brachial artery ultrasound scans were not completed on 132 participants 
because of study drop out prior to scanning visit (n = 82), scheduling problem (n = 15), 
unreadable data (n = 11), study exclusion determined just after screening (n=10), ineligibility 
because of contraindication for brachial artery testing (n = 4), or other reason (n = 10).  The final 
sample of those who completed a brachial artery scan included 168 men and 164 women.   
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Compared to participants who had a brachial artery scans (n = 332), those who were not 
scanned (n = 132) were statistically more likely to be current smokers, less likely to be married 
and had higher total cholesterol and high density lipoprotein levels (data not shown).  Individuals 
who dropped out after the initial visit did not complete psychosocial measures; however, for 
those who did (n=37-53) symptoms of negative affect were similar to scan subjects. 
All subjects provided informed written consent.  The study was approved annually by the 
Institutional Review Board at the University of Pittsburgh. 
4.3.2 Clinical Measures 
A nurse collected clinical measures and medical history screening approximately 2 months prior 
to the ultrasound scan.  This initial visit included a blood draw, anthropometric measures and 
blood pressure assessment after 12 hours fasting. Standard enzymatic assays used to measure 
total serum cholesterol, high density lipoproteins, triglycerides and glucose were completed at 
the Department of Epidemiology Nutrition Laboratory at the University of Pittsburgh.  Low 
density lipoproteins were estimated by the Friedewald equation.  Systolic and diastolic blood 
pressure was obtained while participants were seated for 30 minutes and calculated as the 
average of the second and third measurement.  Height and weight were used to calculate body 
mass index (BMI: kg/m2) and waist circumference was measured at the narrowest width.  
Smoking was categorized at enrollment as current, ever and never.   
4.3.3 Flow-Mediated Dilation 
Brachial arteries were examined using an ultrasound scanner (Toshiba SSA-270A and SAA-
140A, Tustin, CA) equipped with a 7.5-MHz linear array imaging probe.  All scanning was done 
in a dimly lit testing room with the participant in the supine position after 10 minutes of rest.  A 
blood pressure cuff was placed distal to the right elbow with the arm extended out on a board and 
pillow perpendicular to the body.  First, baseline brachial lumen diameter was computed as the 
distance between the lumen-intima interfaces 1-2 centimeters proximal to the antecubital fossa.  
Then the blood pressure cuff was inflated 30 mmHg above the participant’s systolic pressure for 
two minutes.  After release of the cuff, brachial artery images were obtained over three minutes 
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and digitized for later scoring.  At each 30-second interval, end-diastolic images from three 
separate cardiac cycles were averaged from 140 pixel-width measurements taken across one 
centimeter.  Absolute change in diameter was calculated as the peak (widest) of these diameter 
measures minus the baseline brachial diameter.  FMD, the percentage change in brachial 
diameter, was calculated as the absolute difference divided by the baseline brachial diameter 
times one-hundred.  Brachial artery FMD has been found to be a stable and reproducible 
technique.123  Reproducibility in our lab (for 20 women with a second scan within 7 months) has 
previously been reported with an intra-class correlation of 0.72.128  
4.3.4 Psychosocial Measures of Negative Affect 
Measures of negative affect were completed on a computer via self-administered programs 
during three visits scheduled over approximately a four-month time span.  These measures 
included the following published and validated scales: Beck Anxiety Inventory,255 21 items 
measuring the severity of anxiety symptoms; Beck Depression Inventory-II,256 21 items 
measuring symptoms of depression within the past week (rather than the past two weeks as per 
scale protocol); Cook-Medley Hostility Scale,257 50 true/false items assessing cynicism and 
mistrust (where one item was imputed from the other 49 because of an omission error on the 
computer presentation), and three subscales of the Spielberger State-Trait Anger Expression 
Inventory,258 44 items with four-point response scales measuring angry temperament, including 
Anger In (the extent to which feelings of anger are suppressed), Anger Out (the extent to which 
feelings of anger are expressed), and Trait Anger (general feelings of anger / predisposition to 
find a large range of situations to be annoying).  Items were summed within each scale such that 
a higher score indicated more frequent or intense negative affect.  In general, there were high 
positive correlations between the seven measures of negative affect.228  Because scores for 
Anxiety, Depression and Trait Anger were positively skewed, these measures were log 
transformed for analyses.   
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4.3.5 Statistical Analysis 
Baseline characteristics of men and women and univariate associations were evaluated via 
standard statistical methods.  Associations between negative affect and FMD independent of 
traditional cardiovascular risk factors were examined using general linear regression models.  
Models were run separately on men and women because of gender differences in baseline 
brachial diameter size, the positive influence of hormone therapy on FMD in older women 
without clinical cardiovascular disease,259 and to avoid constraining the way in which 
associations between FMD and cardiovascular risk factors were modeled across the two gender 
groups.  Cardiovascular risk factors were chosen a priori based on existing FMD literature and 
included age, systolic blood pressure, BMI and ever smoking, as well as current hormone 
therapy use for women.78,113-117,128,259 [While African American race is positively associated with 
cardiovascular morbidity and other measures of subclinical disease, it has not been linked with 
FMD.113,128,259]  Each measure of negative affect was individually added as the independent 
variable to either the model for men or the model for women.  Change in amount of variance in 
data that was explained by the model and the statistical significance of the psychosocial 
measures were examined.   
To verify that linear analyses were appropriate and that outliers were not unduly 
influencing results, regression analyses were evaluated with scatter plots, quadratic terms, model 
residuals and influence diagnostics.  In some cases, models were re-run to assess the impact of 
highly influential outliers on regression estimates.  
Sex by negative affect interactions were considered in models combining both sexes to 
formally examine potential gender differences in the association between negative affect and 
FMD.  These were generally not statistically significant however, and hence are not reported.  
Additionally, in the female-only models, interactions between hormone therapy use and negative 
affect were evaluated.  
All analyses were implemented using the SAS system for windows version 9.1 (SAS 
Institute, Cary, NC).  Values of p ≤ 0.05 were considered significant.   
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4.4 RESULTS 
4.4.1 Unadjusted Findings 
Participants were 83% Caucasian, 49% female, 76% married, 76% had greater than a high school 
education, and 44% had a total household income of $50,000 or greater.  The sample was 
normotensive with slightly elevated cholesterol, low density lipoproteins and triglyceride levels 
(see Table 4-1).  Gender comparisons showed women had higher high density lipoproteins and 
smaller waist circumference as expected.  Only 7% of the participants were current smokers, 
although males were more likely to be ever smokers.  Fifty-two percent of the women were 
currently taking hormone therapy.  In general, scores showed low levels of negative affect with 
moderate variance.  Women had higher Anxiety scores, while men had higher Hostility scores. 
FMD scores range from -3.6% to 31.7%, with women generally showing greater 
vasodilatation as expected.  Absolute change in brachial diameter was similar across sexes.  In 
looking at univariate associations and cardiovascular risk factors for women, age showed a 
significant negative association with FMD (r=-0.25, p=0.001) and those on hormone therapy had 
greater vasodilatation than those not currently taking hormones (6.74 vs. 5.35, respectively, 
p=0.095).  Measures of blood pressure, lipids, glucose and ever smoking were not significantly 
associated with FMD in overall or sex-specific correlations.   
In stratified univariate analyses between psychosocial scales and FMD, there were 
negative associations with Anger In (Spearman correlation coefficient: r=-0.18, p=0.02) for 
women and with Hostility (r=-0.14, p=0.06) and Trait Anger (r=-0.14, p=0.08) for men, but the 
latter were not statistically significant.  There were also positive associations between FMD and 
Anxiety (r=0.17, p=0.03) and Depression (r=0.13, p=0.08) for women. 
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Table 4-1: Participant Characteristics* 
 All (N=332) 
Men  
(n=168) 
Women  
(n=164) 
Age (years) 60 ± 5 60 ± 5 60 ± 4 
Systolic blood pressure (mmHg) 130 ±15 130 ±15 130 ± 15 
Diastolic blood pressure (mmHg) 80 ± 9 82 ± 9 79 ± 9† 
Total cholesterol (mg/dL) 214 ± 36 208 ± 31 220 ± 39‡ 
High density lipoproteins (mg/dL) 54 ± 16 47 ± 12 61 ± 16§ 
Low density lipoproteins (mg/dL) 132 ± 33 131 ± 28 133 ± 38 
Triglycerides (mg/dL) 119 [84, 170] 125 [91, 189] 113 [79, 158]† 
Glucose (mg/dL) 90 [86, 95] 92 [87, 98] 89 [84, 94]§ 
Waist circumference (cm) 92 ± 12 98 ± 9 86 ± 12§ 
Body mass index (kg/m2) 28 ± 5 28 ± 3 28 ± 6 
Ever smoker 164 (49) 94 (56) 70 (43)† 
Beck Anxiety Inventory (0-63) 4 [2, 7] 3 [1, 5] 5 [2, 8] § 
Beck Depression Inventory II (0-63) 3 [1, 6] 3 [1, 6] 3 [1, 6] 
Cook-Medley Hostility Scale (0-50) 12.2 [8.2, 17.3] 13.3 [9.2, 18.4] 11.2 [7.1, 15.3]‡
Spielberger: Anger In (8-32) 14 [12, 17] 14 [13, 16] 14 [12, 17] 
Spielberger: Anger Out (8-32) 13 [11, 15] 13 [11, 15] 13 [11, 15] 
Spielberger: Trait Anger (10-40) 15 [13, 17] 15 [13, 17] 14 [13, 16] 
Baseline brachial diameter (mm) ^ 3.54 ± 0.67 3.97 ± 0.50 3.09 ± 0.42§ 
Absolute change in diameter (mm) 0.17 ± 0.15 0.16 ± 0.15 0.18 ± 0.14 
Flow-mediated dilatation (%) 5.11 ± 4.82 4.07 ± 3.96 6.17 ± 5.38§ 
* Data is reported as Mean ± SD, Median [IQR] or as n (%).  Comparisons are between men and 
women. 
^ Adjusted for height. 
† p<0.05;  ‡ p<0.01;  § p<0.001 
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4.4.2 Multivariable Regression 
In men, the amount of variation in the data that was explained by a model of just the covariates 
of age, systolic blood pressure, BMI and ever smoking (i.e. traditional cardiovascular risk 
factors) was 0.9% (with an Adjusted R2 of -0.016; Table 4-2).  None of these cardiovascular risk 
factors was significantly associated with FMD (all p > 0.15).  When measures of negative affect 
were added to this multivariable model in individual analyses, hostility was the only measure to 
substantively affect the amount of variation in the data accounted for by the model, increasing 
the Adjusted R2 to 0.011.  Men with higher Hostility had significantly smaller FMD (β=-0.108, 
p=0.02), and those with higher Trait Anger showed a trend toward less vasodilatation (β=-2.360, 
p=0.12).  Removing residual outliers from models did not change associations, although 
exclusion of influential data points (n=10-17) caused slight variations (Hostility: β=-0.097, 
p=0.08 and Trait Anger: β=-3.413, p=0.049).   
In women, the amount of variation in the data that was explained by a model of just the 
covariates of age, systolic blood pressure, BMI, ever smoking and hormone therapy was 11.0% 
(with an Adjusted R2 of 0.080, or 8.0%).  Age was inversely associated with FMD (β=-0.358, 
p=0.0002), and the other cardiovascular risk factors were non-significant.  When measures of 
negative affect were individually added to this multivariable model, women with higher Anger In 
had significantly smaller FMD (β=-0.223, p=0.04).  Additionally, Anger In explained 3.9% of 
the variance beyond the covariate-only model when all women were included and explained an 
additional 5.5% when influential data points were excluded. 
While hormone therapy was not significant in multivariable models, the interactions of 
hormone therapy with Anger In and Anxiety were marginally significant (p < 0.10).  
Specifically, women currently taking hormones showed a significant inverse association between 
Anger In and FMD (β=-0.579, p=0.10), while this association was not significant in women not 
taking hormones.  Conversely, women not on hormones showed a positive association between 
Anxiety and FMD (β=7.70, p=0.04).  
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Table 4-2: Multivariable Generalized Linear Regression Models of Flow-Mediated 
Dilation for Each Measure of Negative Affect by Sex* 
 
 Men Women 
Individual Models β C.I. R2 β C.I. R2 
Base model ^   -0.016   0.080 
Base + Anxiety † -0.493 -1.246, 0.259 -0.012 0.671 -0.532, 1.874 0.083 
Base + Depression † -0.243 -1.004, 0.519 -0.020 0.512 -0.437, 1.461 0.081 
Base + Hostility  -0.108‡ -0.200, -0.015 0.011 0.046 -0.095, 0.186 0.077 
Base + Anger In -0.084 -0.269, 0.102 -0.021 -0.223‡ -0.437, -0.008 0.119 
Base + Anger Out -0.140 -0.379, 0.099 -0.017 0.125 -0.161, 0.411 0.098 
Base + Trait Anger † -2.360§ -5.342, 0.621 -0.010 1.182 -2.920, 5.284 0.096 
* C.I.: Confidence Interval, R2: Adjusted R2 
^ Base model = age, systolic blood pressure, BMI and ever smoked (all p > 0.15 for men); plus 
current hormone therapy in models for women (age p < 0.001, all others p > 0.15).     
† log transformed 
‡ p<0.05 
§ p<0.15 
 
4.5 DISCUSSION 
After controlling for traditional cardiovascular risk factors in healthy older adults, we found 
impaired brachial artery vasodilatation in men with high general anger and hostility, and in 
women with high anger suppression.  Our research bolsters evidence of an association between 
negative affect and cardiovascular health and implies that these links may be evident very early 
in the disease continuum.  We used a larger sample of both men and women than previous 
studies of negative affect and FMD, and our results suggest that cognitive-type measures of 
negative affect in particular may influence endothelial function. 
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Overall, FMD is a useful measure for evaluating the influences of negative affect on 
endothelial dysfunction, a good indicator of cardiovascular health.  The vascular endothelium is 
critical in vascular growth, vasoprotection and vasoregulation.  FMD is thought to reflect nitric 
oxide bioavailability and the effects of shear stress on the endothelium.124-126  Impaired 
vasodilatation is associated with cardiovascular risk factors, such as increased age, systolic blood 
pressure, smoking and BMI, and with lipid-lowering medication;78,113-117 and is a surrogate 
marker for health of the coronary arteries.130,132,133  FMD is impaired in patients with coronary 
artery disease,78,130 is an independent predictor of cardiac risk and events,65,134,135 and has been 
shown to improve with treatment.136,137   
4.5.1 Anger / Hostility 
Our study supports prior evidence of a link between anger/hostility and subclinical 
cardiovascular disease.  In examining FMD, Harris and colleagues128 found an inverse 
association between an aggregate Anger/Type A measure and vasodilatation in postmenopausal 
women.  Trait Anger and Type A personality (and not Anger Out and Hostility measures), as 
well as Anger In, were individually associated with smaller diameter change.  Similarly, a small 
study (n=38) looking at the effects of mental stress found an inverse association between hostile 
affect and FMD in men and women.224  Other subclinical measures show similar relationships, 
including positive associations between measures of anger and hostility with carotid artery 
intima-media thickness (IMT),214,215,217 IMT progression213,216,218,220 and coronary calcification260  
Additionally, hostility and anger show a positive association with cardiovascular risk factors and 
events,209-211,214-216 including mortality.175,212,213   
4.5.2 Depression / Anxiety 
In contrast, we did not find an inverse association between measures of depression and/or 
anxiety with FMD that others have reported.128,221-223,225  Three of these studies221-223 looked at 
current or history of major depression, which was not evaluated in our sample, and one examined 
high depressive symptoms in coronary heart disease patients,225 thus possibly more indicative of 
chronic depression.  In contrast, depression and anxiety in our older adults was skewed toward 
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lower scores, and associations, if any, were in the opposite direction for women.  Interestingly, in 
the large FMD study of healthy women128 the individual scales of Trait Anxiety and Anger In, 
and not depression or social support, were the measures of the Anxiety/Depression cluster that 
were specifically associated with smaller diameter change.  Other measures of subclinical 
cardiovascular disease have also reported a link with a history of two or more major depression 
episodes, but not with depressive symptoms.226,227,229  Similarly, it has been reported that 
sustained anxiety was positively associated with IMT progression in one study,219 but Trait 
Anxiety and general anxiety were not in others,218 including our own.228,229  Thus, chronic 
anxiety/depressive symptomatology may be more influential in early endothelial dysfunction.   
It may also be that anxiety/depressive symptomatology is linked with future morbidity or 
disease progression rather than concurrently measured subclinical cardiovascular disease.  
Notably, in our same sample of healthy older adults, higher depressive symptoms were related to 
3-year change in carotid IMT,228 but not baseline IMT.229  In the Harris et al. study,128 their 
scales were administered an average of 13.6 years (while still premenopausal) and 1.5 years prior 
to FMD measurement.  Additionally, depression and anxiety are consistently noted following 
cardiac surgery for clinical events. 194,195  In the Sherwood et al. study, associations between high 
depressive symptoms and FMD were reported in patients with established cardiovascular 
disease.225  
4.5.3 Etiology and Environment 
Psychosocial traits and stressors influence cardiovascular disease via both pathophysiological 
and behavioral pathways.183-187,252  Pathways involving the vascular endothelium, in particular, 
have been outlined by Harris and Matthews.188  Pathophysiological mechanisms and physiologic 
responses include greater platelet activation,230 exaggerated cardiovascular reactivity (including 
increases in blood pressure and heart rate),231 associations with inflammatory and hemostatic 
markers232,233 and excessive sympathetic nervous system and hypothalamic-pituitary-adrenal axis 
activity (as indexed by greater norepinephrine and plasma cortisol).231,234  Inhibition of cortisol 
improves FMD in depressed patients.235  Substantial overlap exists in the functional and biologic 
pathways underlying these mechanisms and thus, many of these processes may be different 
manifestations of the same etiology.   
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Lifestyle behaviors, environmental situations and genetic factors also influence the 
association between negative affect and vascular health.  Negative emotions have been linked to 
adverse health habits, including poor sleep, increased alcohol use, smoking, obesity and poor 
diet.175-178,192  Individuals with negative dispositions are also less likely to adhere to medical 
interventions and to seek or have access to medical care.179,180  While it is not clear whether 
negative emotions mediate the association between health and social economic status,192,193 
individuals from higher and lower statuses clearly differ in how they describe their social 
environment and interactions with others.238-240  A study of young adult twins also suggests that 
non-shared environmental factors influence negative affect.189  Behavioral factors are highly 
influential,175 but do not solely account for associations between psychosocial traits and 
cardiovascular disease; and psychosocial influences are evident even after controlling for 
traditional cardiovascular risk factors.211,216,217  Genetics likely play a role, predisposing both 
psychological factors and physiological vulnerabilities.189-191  
Given the cross-sectional nature of the analyses reported here, a causal relationship 
between vascular system dysfunction and psychosocial traits can not be established. 
Furthermore, genetic and environmental predispositions underlie both entities. Our study did 
reduce some of the confounding influences that may impact such associations by evaluating 
healthy individuals.  In showing that the influence of negative affect on cardiovascular health is 
not limited to individuals with established cardiovascular disease, this study suggests, in any 
case, that such associations may develop early in the disease process.   Hostility, anger, 
depression and anxiety are enduring and relatively stable psychosocial characteristics, and as 
such are appropriate for examining influences on subclinical cardiovascular disease in both men 
and women. 
4.5.4 Considerations 
While there is an overlap in psychosocial risk factors such as hostility, anger, anxiety, depression 
and other constructs,173,189,261 a relationship with FMD was not found with all measures in our 
study.  Additionally, post hoc attempts to create aggregate measures of negative affect did not 
produce stronger associations.  It is feasible that some psychosocial measures have stronger 
construct validity or allow for greater variance even among mildly affected individuals (as our 
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sample was); or that our use of concurrently measured psychosocial traits influenced some 
results.   
Alternately, it is possible that attitudinal or cognitive measures of hostility and anger, as 
well as major clinical depression, might be more influential early in the disease process (i.e. 
endothelial dysfunction), while depressive symptomatology may be more compatible later with 
atherosclerotic progression228 and clinical outcomes.55,57  Considerable overlap has been reported 
in the constructs of hostility, cynicism and anger.173,174  While depression and anxiety are often 
considered together, the intercorrelation of emotions vary among samples,173 and the levels of 
depression and anxiety in our participants were lower than other healthy groups (while the anger 
measures were comparable).  Of note, people who score high on measures of Anger In and 
Hostility tend to ruminate a lot about others, but are not necessarily more physically aggressive 
or violent than others in the general population, and it may be this particular trait that is most 
congruent with early subclinical cardiovascular disease.   
Of mention, in our analyses no correction was made for multiple comparisons; thus our 
results should be interpreted with caution.  However, the literature suggests this may not have 
been necessary given our hypotheses.262,263  While an interaction effect between sex and negative 
affect was not found, we reported slight variations in which scales were associated with FMD in 
each gender.  This may have been due to the influence of hormone therapy,113,128,259 to the wider 
variance in respective scales for men and women, to the influence of age on FMD in women, or 
to measurement “noise” in the paradigm of cognitive-type constructs of anger/hostility.  
4.5.5 Conclusions 
In conclusion, hostile, mistrustful attitudes and a tendency to harbor unexpressed anger were 
shown to be associated with impaired vasodilatation of the brachial artery in healthy older adults.  
This study adds the measure of FMD to the literature on the association of negative affect and 
cardiovascular health, confirms that such associations may be present for men as well as women, 
and suggests this connection may be apparent very early in the disease process. 
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5.0  DISCUSSION AND CONCLUSIONS 
5.1 OVERVIEW OF FINDINGS 
Following is a review of the main findings of the complete papers presented in Chapters 2-4.  A 
brief accounting of how these findings compare and contrast to the existing literature is also 
presented.  Each synopsis is completed with the theories supporting the findings and conclusions 
that were drawn.   
5.1.1 Traditional Risk Factors and Segment Specific IMT 
In the first paper, we evaluated the extent to which intima media thickness (IMT) in three 
locations within the carotid artery were differentially associated with traditional cardiovascular 
risk factors.  Starting with separate linear regression models, adjusted for age, menopausal status 
and intervention group, we found baseline weight, systolic blood pressure and age independently 
and positively associated with common carotid artery IMT.  In the bifurcation area, we found 
smoking, higher weight and higher systolic blood pressure independently associated with higher 
IMT.  IMT in the internal carotid artery was independently and positively associated with 
apoprotein B.  Then using a multivariable repeated measures mixed model of all three IMT 
locations, we were able to show differential effects whereby these risk factors had segment-
specific associations.  Specifically, the effect of weight was strongest and aging was limited to 
the common carotid artery, smoking and systolic blood pressure associations were specific to the 
bifurcation area of the vessel, and the effect of apoprotein B was strongest in the internal carotid 
artery segment. 
Similarities between our results and previous research include positive associations of 
body composition and systolic blood pressure with common carotid and bifurcation IMT,10,11,13 
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lipids associated with internal carotid and bifurcation IMT,9,11,13 and smoking with IMT in the 
bifurcation.11  However, others have generally found the segments similarly associated with 
cardiovascular risk factors,10,11,13 whereas we found distinct differences in risk factor and 
segment associations in healthy middle-aged women.   
Our findings that risk factors differentially influence IMT locations can be substantiated 
based on previous research of arterial hemodynamics, shear stress and vascular biology.  Each 
area of the carotid arterial vessel experiences variations in hemodynamics and cellular processes, 
which affect the development and progression of disease.14-22  Additionally, the risk factors 
themselves are likely acting in conjunction and possibly synergistically with various 
biomechanical and biochemical pathways to determine the development and progression of 
atherosclerosis at any given site.16,20,23,24  Further, each site may have its own predisposing 
factors.12,19  Thus, the pathophysiology of the arteries and the biomechanics of the individual risk 
factors support our findings of significant and targeted associations between traditional 
cardiovascular risk factors and carotid arterial segments even after accounting for the correlation 
in IMT at all three locations. 
5.1.2 Rheumatoid Arthritis and Carotid Outcomes 
In the second paper, we assessed whether diagnosis of rheumatoid arthritis and indicators of the 
disease were associated with measures of carotid atherosclerosis and vascular health.  Lumen 
diameter and interadventitial diameter were significantly wider in patients with rheumatoid 
arthritis than in healthy women.  After controlling for age, African American race, hypertension, 
hypercholesterolemia, glucose, height and IMT, diagnosis of rheumatoid arthritis continued to be 
associated with larger lumen and interadventitial diameters.  Prevalence of plaque was higher in 
patients but not statistically different than healthy women.  Carotid IMT was similar between 
groups.  In patients with rheumatoid arthritis, we found positive associations between 
methotrexate dose and interadventitial diameter, between prednisone use and hypothyroidism 
and IMT, and between hypothyroidism and soluble endothelial adhesion molecule and plaque, 
independent of cardiovascular risk factors.  And while additional indicators of rheumatoid 
arthritis severity or activity were not significantly associated with carotid outcomes in 
multivariable models, other inflammatory markers and medications showed significant trends.   
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Our finding of similar IMT between groups is consistent with several studies of 
rheumatoid arthritis patients conducted in the United States, 91,92,94 but in contrast to others’ 
findings, 84-89,95  although others have reported on slightly older patients with a wider age 
spectrum, and enrolled both men and women.  We suspect that our sample of slightly younger 
women with a narrower age range may have been studied at an earlier point on an arterial 
remodeling continuum than those described elsewhere, with our women with rheumatoid arthritis 
having vessel wall dilatation and thus preserved IMT.  Alternatively, differences in study results 
may be due to a unique, rheumatoid arthritis-related modification of atherogenesis whereby the 
progression of disease is different from other conditions where increased IMT is seen early.   
Like others we found measures of rheumatoid arthritis severity and inflammation, 
including disease duration, medication use and soluble endothelial adhesion molecule, positively 
related to carotid atherosclerosis.85,86,94,95,161,169,171,196,197  Literature reviews suggest chronic 
systemic inflammation may lead to endothelial dysfunctions and accelerated atherogenesis in 
patients with rheumatoid arthritis.166-168,244  Links with measures of rheumatoid arthritis activity 
may be particularly interesting given that traditional cardiovascular risk factors are not 
consistently associated with atherosclerosis in patients with rheumatoid arthritis.156,158,170,171   
Given our results, it can not be said with certainty whether all women with rheumatoid 
arthritis have greater IMT than healthy controls, or if this difference is only observed in women 
of certain ages or ethnicities, or at particular time points in the course of disease (rheumatoid 
arthritis or atherosclerosis).  Nonetheless, we believe that lumen and interadventitial diameters 
may be more sensitive measures of early atherosclerosis in rheumatoid arthritis than ultrasound 
measurement of IMT and plaque.  These findings, as well as associations of disease severity with 
carotid outcomes may indicate evidence of accelerated vascular aging and early atherosclerotic 
risk among women with rheumatoid arthritis. 
5.1.3 Negative Affect and Flow-Mediated Dilation  
In the third paper, we identified measures of negative affect inversely associated with 
endothelial-dependent flow-mediated dilation (FMD) of the brachial artery in both men and 
women.  Univariate correlations between psychosocial scales and FMD showed a significant 
negative association with anger suppression for women, and a trend for a negative relationship 
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with hostility and general feelings of anger for men.  After controlling for traditional 
cardiovascular risk factors of age, systolic blood pressure, body mass index and ever smoking, 
FMD was associated with higher hostility and general anger scores in individual multivariable 
models for men.  In women, after also controlling for current hormone therapy, we found 
decreased FMD was independently and significantly associated with higher anger suppression 
scores.  We did not find significant associations between measures of anger expression, 
depressive symptoms or anxiety with FMD in using these multivariable models.   
Our study is consistent with others who have found a link between anger/hostility and 
subclinical cardiovascular disease,213-218,220,260 including reduced vasodilatation in 
postmenopausal women128 and in combination with mental stress task.224  In contrast, we did not 
find a statistically significant association between measures of anxiety/depression with FMD as 
previously reported.128,221-223,225  However, previous reports examined major depression or prior 
symptomatology, 221-223 while we evaluated concurrent depressive symptoms.  Results of other 
measures of subclinical cardiovascular disease have also shown an association with a history of 
major depression episodes, but not with depressive symptoms.226,227,229  However, depressive 
symptoms show positive associations with IMT progression and in heart patients.1,5,7,194,195  
Previous results for anxiety and subclinical disease have been mixed.128,218,219   
Both behavioral and biological influences contribute to the association between negative 
affect and disease.  Positive associations have been found between negative affect and poor 
health behaviors (e.g. smoking, unhealthy diet, inactivity) including treatment non-adherence and 
low socio-economic status.175-182,192,193  Pathophysiological mechanisms by which negative affect 
may be linked to cardiovascular disease include excessive sympathetic nervous system and 
hypothalamic-pituitary-adrenal axis activity,231,234 greater platelet activation,230 
inflammation,232,233 and exaggerated cardiovascular reactivity such as increased blood pressure 
and heart rate.231  Genetic and environmental influences are also important aspects to the 
relationship between negative emotions and cardiovascular disease.189-191   
We conclude that attitudinal or cognitive measures of anger and hostility (and major 
clinical depression reported in other studies 221-223) might be more influential early in the disease 
process (i.e. endothelial dysfunction), while depressive symptomatology may be more 
compatible later in atherosclerotic progression157 and with clinical outcomes.55,57,194,195  In sum, 
our study found hostile attitudes and a tendency to harbor unexpressed anger were associated 
 97
with impaired vasodilatation of the brachial artery in healthy older adults, and thus supports 
evidence of a link between anger/hostility and subclinical cardiovascular disease in men and 
women.   
5.2 GENERAL DISCUSSION 
These three papers illustrate that ultrasound measures of subclinical cardiovascular disease and 
vascular health can be used to assess relationships with putative risk markers including, 
traditional cardiovascular risk factors, diagnosis of rheumatoid arthritis and measures of negative 
affect.  Evaluating subclinical cardiovascular disease, especially in otherwise healthy samples,  
suggests associations are present early in the disease process.  Several common themes can be 
drawn from the three papers just presented, including the use of ultrasound measures in healthy 
samples, the influences of aging and hemodynamics, and the use of female participants.  There 
are also unique characteristics and specific contributions to the literature for each paper that can 
be appreciated.  Finally, potential weaknesses of each study will be considered. 
5.2.1 Common Themes 
While we used three different study samples and evaluated a variety of ultrasound measures and 
risk markers, several common themes can be drawn from the three papers just presented.  Mutual 
topics include the application of ultrasound to assess subclinical measures of disease and 
vascular health, the use of healthy adult participants, the influence of aging on the cardiovascular 
system, the focus on samples of women, and the implications of hemodynamics on the 
adaptation of the vasculature.   
5.2.1.1  Noninvasive Ultrasound Measures. We used ultrasound measures to examine 
the carotid artery in two studies and looked at the brachial artery in the third.  We showed that 
multiple outcomes show associations with putative markers of risk, suggesting that insult to the 
vasculature is not limited to a single vessel.  However, we also learned that insults may not be 
universally influential given the differential associations seen by IMT segment in healthy 
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middle-aged women, and in diameters but not IMT when comparing women with rheumatoid 
arthritis to healthy women.  While not fully “interchangeable” because of their particular 
assessments, measures of IMT, plaque, diameters and FMD could have been substituted for one 
another in the three studies.  That is, each of these ultrasound tools is not uniquely associated 
with the putative maker of risk examined, but rather indicative of underlying cardiovascular 
disease and vascular health. 
5.2.1.2  Healthy Samples.  By design all three studies looked at subclinical 
cardiovascular disease and vascular health, thus by definition outwardly healthy participants and 
pre-clinical measures of disease were evaluated.  In all three cases, we utilized a “healthy heart” 
sample or controls, so that putative risk factors could be examined without the influence of 
known disease.  For studies of negative affect in particular, associations with cardiovascular 
disease are more consistently found in healthy populations, presumably because fewer 
confounder effects exist.173  In showing that the influence on cardiovascular health is not limited 
to individuals with established cardiovascular disease, we support targeting interventions to 
vulnerable individuals early in the disease process. 
5.2.1.3  Vascular Aging. While one of the goals of cardiovascular disease prevention is 
to promote healthy aging, the passage of time still has a seemingly inevitable influence on the 
vascular system.  It has been postulated that increasing age contributes both to changes in the 
cardiovascular structure and function as well as interactions with and resulting from an increased 
exposure time to various risk factors.58,59,264  In the first paper, we found aging was associated 
with IMT in the common carotid artery even when controlling for cardiovascular risk factors and 
IMT in the other segments.  In the rheumatoid arthritis paper, in the absence of other risk factors, 
aging and the duration of disease were associated with IMT.  Finally, in the third paper aging 
showed an inverse relationship with FMD of the brachial artery in women, possibly indicative of 
their younger biologic cardiovascular age as compared to men.  Thus, we showed that aging has 
an effect on multiple vascular beds and on various indicators of atherosclerosis and vascular 
health.  Lakatta and Levy suggested that the combination of age-associated endothelial 
dysfunction, intima media thickening, arterial stiffening and pulse pressure widening along with 
risk factor exposure and genetic makeup determine an individual’s overall vascular aging profile 
and lead to the most unsuccessful cardiovascular aging.59 
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5.2.1.4  Female Samples.  An extensive review of MEDLINE studies from 1966 through 
1998 showed that women have been underrepresented in clinical trial of cardiovascular disease.69  
In a detailed review of 724 manuscripts from specific publications and years, Meinert and 
colleagues concluded that male participants outnumbered females 3.66 to 1 in heart disease 
clinical trails.69  Further, while the representation of women in cardiovascular clinical trials has 
increased due to a few large, single-sex trials, women are still underrepresented in the evaluation 
of particular heart conditions, and there has been no change over time in the sex composition in 
the majority of cardiovascular disease studies.68,69  The American Heart Association has 
concluded that men and women differ with respect to disease processes, clinical presentations 
and outcomes and thus has established guidelines for cardiovascular disease prevention specific 
to women.43,70,265  Differences between genders are often attributed to the effects of estrogen on 
the vascular system, including lowering lipid concentrations, increasing nitric oxide secretion 
and vasodilation, and altering fibrinolytic, coagulation and antioxidant systems.266  Thus, the 
assessment of vascular health and aging in women was of particular interest here.  
The first two papers we presented used female-only samples.  In Chapter 2, we applied 
methodology to the Women’s Healthy Lifestyle Project, a diet and exercise intervention trial in 
premenopausal women.  While the novel associations we found were unlikely to be gender-
specific, the original study likely contributed to the recent gains sited in participation of women 
in clinical trials.  In our second paper, it was natural to focus on the vascular health of women, 
because rheumatoid arthritis is more common in women than men.  Thus, from both a logistic 
perspective (in terms of recruitment and statistical power) and application of the findings, using a 
sample of only women was most effective.  In the third paper, we were able to assess the 
associations of negative affect in both men and women.  And although sex-specific interactions 
were not found, we reported differential associations for men and women.   While the issue of 
adequate representation of women in cardiovascular research remains debatable267 and sex 
difference exist in willingness to participate may explain some discrepancies,268 making use of 
female samples is worthwhile.  
5.2.1.5  Adaptation of the Vasculature.  Hemodynamics and cellular processes of the 
vascular system influence the adaptive and moderating responses of the arterial vessels.  Shear 
stress is inversely related to age, systolic blood pressure, body mass index, carotid diameter, IMT 
and plaque18,19,109,140,141 and positively related to FMD.127  The greater the viscosity and velocity 
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of the blood the greater the shear stress, resulting in insult and adaptation of the endothelial cells 
and vascular wall.269,270   
Two of the papers portray the continually changing environment of the carotid arteries 
and the ability of the vasculature to respond.  When considering carotid segments, we saw that 
the high oscillatory blood flow inherent to the bifurcation produces greater IMT and plaque than 
is found in the common carotid artery, which is prone to laminar blood flow.  This “negative” 
response mirrors the “positive” vascular adaptation seen in the women with rheumatoid arthritis.  
These patients had larger arterial diameters than healthy women, presumably to moderate tensile 
stress of the dilated artery and maintain constant blood flow in response to arterial wall 
thickening.   
5.2.2 Unique Characteristics and Contributions to the Literature 
In addition to the common themes, each paper possesses unique characteristics allowing the 
breadth of research and knowledge gained by this investigation to be appreciated.  The paper on 
rheumatoid arthritis has the biggest potential for clinical application as rheumatologists continue 
to tease out specific aspects of the disease most relevant to cardiovascular disease development.  
Our findings that hypothyroidism, medication use and inflammatory markers were associated 
with carotid diameters, IMT and plaque make these important rheumatoid arthritis-related 
characteristics for clinicians to track.   
The segment-specific IMT paper showed that proper statistics applied to a dataset can 
facilitate new insight and add certainty to associations that are found.  Epidemiologists need to 
keep current on and take advantage of advances in statistical software and techniques to ensure 
that they are gleaning the most accurate conclusions from their results.  We demonstrated that a 
repeated measures statistical model can be applied to data that is biologically correlated, rather 
than data with multiple time points, thus improving upon conclusions drawn from separate 
regression analyses.   
The paper on negative affect and FMD was the only one of the set that looked at the 
brachial artery and included both men and women.  When feasible, studies should enroll both 
men and women (and multiple race/ethnicities), increasing the chance that findings will be 
applicable to a wider population. 
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In addition to their unique characteristics, each paper made an individual contribution to 
the literature on subclinical cardiovascular disease and vascular health with regards to putative 
markers of risk.  First, in looking at carotid IMT by segment, we found that traditional 
cardiovascular risk factors were differentially associated with each segment even after 
accounting for the correlation in wall thickness between segments.  Thus, when comparing and 
evaluating IMT results between studies it is important to consider which segments are included 
in measures of arterial thickening.   
Second, we raised the possibility that vascular adaptation may explain mixed results in 
the literature comparing IMT in patients with rheumatoid arthritis to healthy controls.  Our 
findings of greater carotid artery diameters but similar IMT in women with rheumatoid arthritis 
compared to healthy women, suggest that the timing of assessment (i.e. chronological age, 
rheumatoid arthritis duration and vascular aging) is important.  Therefore, it is important to 
consider where in the disease continuum patients may be and what rheumatoid arthritis-related or 
atherosclerotic adaptations may be influencing wall thickness.   
Third, in finding an inverse association between hostile attitudes and anger suppression 
with brachial artery FMD, we demonstrated that cognitive-type measures of negative affect may 
influence endothelial function.  It has been suggested that insult to the endothelium occurs prior 
to measurable atherosclerosis,138 therefore future studies may want to consider using FMD in 
addition to or instead of the more commonly used measures of subclinical cardiovascular 
disease. 
5.2.3 Limitations and Weaknesses  
While each study made important contributions to the literature, they were not without 
limitations.  Ideally, the study of IMT segments would have included men and had greater ethnic 
diversity.  Having a broader pool of participants would have increased the generalizability of the 
results.  Nonetheless, we chose to make use of a female-only dataset in an effort to balance the 
existing research on cardiovascular disease, which has often evaluated only male subjects.  The 
field now clearly recognizes that the development and course of disease in women may differ 
from men,43,70 therefore, applying these analyses to a broader sample would be beneficial.   
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In women with rheumatoid arthritis we found soluble endothelial adhesion molecule 
positively associated with plaque prevalence.  However, no other statistically significant 
association with markers of inflammation or in conjunction with carotid diameters or IMT was 
seen in multivariable models.  Review of the literature suggest chronic systemic inflammation 
may lead to endothelial dysfunction,166-168,244 so it is unknown whether we examined these 
markers at the wrong time point in the disease continuum or if repeated measures of systemic 
inflammation (rather than a single reading) would have shown stronger results.   
In the third paper, where distinct associations between negative affect and FMD were 
reported, a larger sample size, younger population or greater variance in negative symptoms 
might have produced more robust results.  Interestingly, our participants reported levels of anger 
and hostility that were similar to others, but lower levels of depression and anxiety compared to 
other normal populations.  While we provided valid and well substantiated results, we had 
postulated stronger associations and a greater number of scales with significant findings. 
Finally, all three papers evaluated cross-sectional associations with ultrasound measures 
of cardiovascular disease, which are not clinical endpoints themselves.  A causal pathway 
between the markers of risk and the outcomes studied can not be established.  Further, it can not 
be said with certainty which individuals will experience acute cardiovascular events or develop 
overt signs of disease.  Established guidelines regarding how to monitor or treat individuals with 
subclincial disease are lacking.  Nonetheless, our findings contribute to the broader knowledge of 
vascular aging and cardiovascular health. 
5.3 PUBLIC HEALTH SIGNIFICANCE 
The research summarized here has several public health implications.  These include 
appreciation of multiple risk markers, analytic methods and subclinical measures of 
cardiovascular health.  Additionally, further evaluating the specific needs of women with heart 
disease (as previously discussed) and addressing primordial and primary prevention are critical. 
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5.3.1 Putative Markers of Risk 
It is important for both clinicians and scientists to consider the global picture of heart health 
when treating patients and designing research studies.  While traditional cardiovascular risk 
factors are clearly linked to both clinical and subclinical cardiovascular outcomes, our research 
showed that other aspects of health, including other chronic conditions (such as rheumatoid 
arthritis) and psychosocial symptoms (such as negative affect) are associated with indicators of 
heart health.  Thus, a large range of putative markers of risk should be factored into evaluation, 
prevention and treatment of disease.  
5.3.2 Statistical Evaluation 
We also showed the importance of appropriate and thorough statistical evaluation in 
epidemiologic studies.  While it should be standard practice to include various statistical methods 
to thoroughly evaluate ones findings, they are sometimes overlooked in the haste to report results 
or because findings match hypothesis.  While somewhat time consuming, additional statistical 
evaluation can strengthen ones conclusions or reveal potential pitfalls, and thus are critical to 
include in one’s own results and important when considering those stated by others. 
As mentioned already, the use of a mixed regression model, allowed for an impartial 
evaluation of the three carotid artery segments, thus providing an unbiased assessment of 
segment-specific associations.  While similar results were found using individual multivariable 
models, there was greater overlap amongst IMT locations.  In other words, several risk factors 
were associated with more than one segment.  In contrast, the mixed model was able to tease out 
more distinction relationships.  
In making good use of regression diagnostics and model residuals, as was done in the 
FMD and negative affect paper, the chance of spurious results based on a few outliers was 
decreased.  Given that multiple models were run to individually assess associations for each 
measure of negative affect for each gender, the possibility of finding chance correlations was 
increased.  Further, while several outliers existed (as evidenced by residual plots and influential 
diagnostics) the remaining observations showed limited variance.  Thus, the additional analyses 
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added confidence to the reported results by showing consistent associations across multiple 
analytic evaluations of each measure of negative affect.   
5.3.3 Application of Ultrasound Measures 
Ultrasound measures of subclinical cardiovascular disease and vascular health and adaptation are 
useful as research benchmarks and as screening tools for specialty populations.  Noninvasive 
measures of disease are ideal for research studies because they have minimal adverse outcomes 
(if any) to study subjects, while also providing the opportunity to evaluate individuals without 
overt disease.  When evaluating the effects of an intervention study with specialty populations 
(e.g. patients with rheumatoid arthritis, obese individuals), evidence of vascular adaptation (i.e. 
changes in carotid diameters and IMT) would be particularly applicable.  Using FMD to track 
pharmacological treatments in hypertensive patients has also been suggested.271,272  The 
subclinical disease measures used here, particularly IMT, may also be applicable for noninvasive 
diagnostic and prognostic testing of high risk individuals or in cases where standard screening 
tools are inconclusive.273  FMD has the potential for use in patient identification for early 
prevention, although additional research is needed to determine the efficacy of endothelial 
function testing in cardiovascular disease risk assessment.72,274  In sum, use of ultrasound 
measures of disease is warranted for both clinical and research settings. 
5.3.4 Cardiovascular Disease Prevention 
In addition to the specific public health implications mentioned, one should also consider the 
more global perspective of cardiovascular disease prevention.  According to the Centers for 
Disease Control and Prevention National Center for Health Statistics, life expectancy would rise 
by nearly seven percent if all forms of major cardiovascular disease were eliminated.44,45  Given 
the multiple genetic, environmental and behavioral influences on the development of 
cardiovascular disease, the road to prevention can be quite daunting.53,54  Granted, secondary 
prevention can sometimes be viewed as more cost effective (i.e. because higher risk patients 
garner more benefits), and easier for the medical community and insurance companies to track 
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and target.  However, for fundamental lifestyle changes to occur community programs, societal 
changes, and support from medical and health care institutions are needed.53,54,150,165,275,276   
The World Health Organization states that the most important causes of heart disease are 
due to “modifiable risk factors” of physical inactivity, unhealthy diet and tobacco use, and that 
80% of cardiovascular disease deaths could be avoided by changing these behaviors.42  
Psychosocial factors, such as perceived stress and depression, may be similarly influential.55,57  
While medications are very effective in secondary prevention,148 to achieve a major reduction in 
disability and deaths due to cardiovascular disease the focus needs to be on changes in the 
modifiable risk factors not a cure.42  Therefore it is recommended that individuals avoid tobacco 
use and second-hand smoke, engage in 30 minutes of daily physical activity, maintain a healthy 
body weight, and choose a diet rich in fruits, vegetables, whole grains and nuts, while avoiding 
foods high in salt, sugar and fat.42,53,148  Unfortunately, only three percent of those surveyed in 
2000 met all four Healthy Lifestyle Indicators of nonsmoking, healthy weight, five fruits / 
vegetables and regular physical activity.277  These healthy behaviors go hand-in-hand with a 
positive psychosocial disposition and are directly linked to traditional cardiovascular risk factors, 
suggesting that the umbrella of cardiovascular research is quite large and rightfully so given the 
enormous public health implications.  
5.4 FUTURE RESEARCH AND APPLICATIONS 
As just mentioned the three papers suggest several theoretical implications including, utilizing 
appropriate statistical methods and carefully evaluating others work when drawing conclusions 
and making comparisons.  Beyond these, the works described lay the groundwork for future 
research in terms of both immediate “next steps” and broader applications.   
The logical progression for each of the individual studies would be to follow up on the 
unanswered questions by broadening their scopes and carrying through on conclusions drawn.  
Thus, the study of segment-specific IMT risk factors could readily be applied to other existing 
datasets.  By choosing studies of males, varying ages and multiple ethnicities, the 
generalizability of the reported results could be demonstrated.  For the second paper the obvious 
next step would be to test our theory that vascular adaptation accounted for the difference in 
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diameter and similarities in IMT between patients with rheumatoid arthritis and healthy women.  
Thus, the women with rheumatoid arthritis would be brought back for an additional carotid 
ultrasound scan(s) so that the progression of IMT and diameters could be tracked.  These data 
could then be compared to the healthy controls, who had multiple carotid scans as part of their 
original carotid study.  Similar to the first paper, the study of negative affect would benefit by 
testing if similar associations were found in additional populations, particularly younger 
participants and those with more profound negative dispositions.  In recruiting healthy, 
motivated volunteers, our study may have been limited by selection bias. 
From a broader perspective, research on putative marker of risk and subclinical 
cardiovascular disease and vascular health could go in many directions.  Of those who die of 
coronary heart disease, half of men and nearly two-thirds of women have no prior symptoms,43,47 
leaving much to be discovered.  The three studies presented here evaluate only a small fraction 
of the multitude of factors affecting cardiovascular disease.  Future studies should continue to 
evaluate other markers of risk and make use of ultrasound sound measures as surrogate markers 
of disease as well as endpoints in themselves.  For example, researchers could use these 
subclinical measures to track the effects of a treatment or intervention study by assessing 
vascular health and adaptation in hypertensive, obese, systemic lupus or similar samples.  This 
could be done by obtaining a baseline scan, implementing medications or healthy lifestyle 
program, and then checking follow-up scans to evaluate treatment success.   
While research applications are most promising, ultrasound measures also have some 
potential for clinical practice.  For example, the measures employed here could be included in 
the battery of clinical tests used to evaluate cardiovascular disease in both at risk and high risk 
populations.  Exercise treadmill testing and stress cardiac imaging can accurately diagnosis and 
risk-stratify individuals with known and suspected cardiovascular disease.  Nonetheless, new 
approaches could supplement current screening tools.273,278  This is especially true in women for 
whom the symptom presentation often differs from that traditionally seen in men.  Use as a 
screening tool may also be helpful in identifying at risk individuals for whom intervention early 
in the disease process would be beneficial.  The measures of common carotid IMT and carotid 
plaque are the most likely candidates for clinical application given their high reproducibility and 
clear link with cardiovascular morbidity and mortality; while evaluating endothelial dysfunction 
via FMD may provide an even early assessment of vascular health. 
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A third implication of this dissertation is the need to include psychosocial measures in 
large epidemiologic studies of cardiovascular disease.  The psychosocial measure in the 
INTERHEART study included primarily questions on perceived stress and depression.57  Given 
the associations we and others have reported, questions on anger and hostility should be included 
in a world-wide epidemiologic study with cardiovascular disease measures and outcome events.  
A study of this type and magnitude would have the potential to notably substantiate current 
research. 
5.5 CONCLUSIONS 
Subclinical ultrasound measures are useful for studying associations early in the disease process.  
At one of the earliest stages of cardiovascular disease, we looked at endothelial dysfunction via 
vasodilatation of the brachial artery and found it inversely associated with hostile attitudes and 
tendency to harbor unexpressed anger.  In finding wider carotid artery diameters in women with 
rheumatoid arthritis compared to healthy women, we suggest that these may be more sensitive 
measures of early atherosclerosis in rheumatoid arthritis than ultrasound measurement of IMT 
and plaque, and that vascular adaptation may explain previously reported discrepancies.  We also 
showed that cardiovascular risk factors may differentially affect IMT in the common carotid, 
bifurcation and internal carotid artery segments of healthy middle-aged women when wall 
thickness in all three segments is simultaneously taken into account.  Thus, the works described 
here were successfully able to evaluate early signs of atherosclerosis and vascular health and 
aging in conjunction with putative markers of risk.   
The path to cardiovascular morbidity and mortality occurs in conjunction with a range of 
factors.  Traditional cardiovascular risk factors are most obvious, but do not completely explain 
the story, thus other avenues must be considered.  We were able to demonstrate that diagnosis 
and characteristics of rheumatoid arthritis and measures of negative affect were associated with 
subclinical cardiovascular disease.  Insult to the cardiovascular system does not occur in a 
vacuum and both public health programs and epidemiologic research should target an array of 
risk factors, particularly those that are modifiable.  Healthy lifestyle behaviors, genetic 
predispositions, negative emotions and environmental conditions are all acting together to 
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influence cardiovascular disease and vascular aging.  Therefore, when evaluating cardiovascular 
health it is important to consider psychosocial traits and co-morbid disease conditions and 
disorders in combination with traditional cardiovascular risk factors.  
Research evaluating relationships with endothelial dysfunction, atherosclerosis and 
vascular health are informative measures regarding influences early in the disease process.  In 
addition to evaluating specific relationships, we validated the more general influences of 
hemodynamics and vascular aging, utilized a range of statistical methods, demonstrated the 
importance of critical evaluation, and supported the inclusion of women in cardiovascular 
research.  We evaluated the public health implications of our research and endorsed the need for 
individuals to adopt a healthy lifestyle.  In conclusion, evaluating associations between putative 
markers of risk and subclinical cardiovascular disease and vascular health provides insight into 
the broader epidemic of heart disease. 
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